Skip to main content
Cellular and Molecular Life Sciences: CMLS logoLink to Cellular and Molecular Life Sciences: CMLS
. 2021 Jun 1;78(13):5341–5370. doi: 10.1007/s00018-021-03846-2

Electrophysiology of ionotropic GABA receptors

Erwan Sallard 1,2,, Diane Letourneur 3,4, Pascal Legendre 5
PMCID: PMC8257536  PMID: 34061215

Abstract

GABAA receptors are ligand-gated chloride channels and ionotropic receptors of GABA, the main inhibitory neurotransmitter in vertebrates. In this review, we discuss the major and diverse roles GABAA receptors play in the regulation of neuronal communication and the functioning of the brain. GABAA receptors have complex electrophysiological properties that enable them to mediate different types of currents such as phasic and tonic inhibitory currents. Their activity is finely regulated by membrane voltage, phosphorylation and several ions. GABAA receptors are pentameric and are assembled from a diverse set of subunits. They are subdivided into numerous subtypes, which differ widely in expression patterns, distribution and electrical activity. Substantial variations in macroscopic neural behavior can emerge from minor differences in structure and molecular activity between subtypes. Therefore, the diversity of GABAA receptors widens the neuronal repertoire of responses to external signals and contributes to shaping the electrical activity of neurons and other cell types.

Keywords: Synaptic receptor, GABAA subtypes, Neurotransmitter, Neuronal inhibition, Phasic currents, Tonic activity

Introduction

γ-Aminobutyric acid (GABA) is one of the main neurotransmitters in virtually all Metazoans. It is the most widely distributed inhibitory neurotransmitter in the central nervous system of mature vertebrates, being present in around 30% of the synapses [1, 2].

GABA-mediated signals can be transduced in receiving cells through metabotropic or ionotropic receptors located at the plasma membrane. GABAB receptors are heterodimeric metabotropic receptors coupled to potassium and calcium channels through G proteins. On the other hand, GABAA receptors are GABAergic pentameric chloride channels [3], i.e. ionotropic GABA receptors, belonging to the cys-loop family of ion channels [4]. Certain ionotropic GABA receptors were initially termed GABAC receptors [5], but they are now classified as a subset of GABAA receptors [6].

GABAA receptors are found in all major taxa of bilateral metazoans [7] and are among the most abundant neurotransmitter receptors [8]. They are mainly found in neurons in synaptic, perisynaptic, and extrasynaptic locations. They can also be found in non-neuronal cells as well as outside of the nervous system.

The monomers constituting GABAA pentameric receptors are drawn out of a large set of different subunits. Consequently, GABAA receptors can be made of different combinations of subunits and are subdivided into subtypes: each subtype corresponds to a combination of subunits. Subtypes can differ in their electrophysiology and their pharmacology. The total number of functional subtypes existing in vivo may reach several hundreds [9], although most receptors belong to one or two dozens of major subtypes [10].

The conductance and current time-course of GABAergic receptor-channels depend on their subunits composition, the ionic conditions of their environment and the patterns of GABA exposure they face. In particular, the differential regulation, abundance and localization of GABAA receptor subtypes enable a very precise modulation and a great diversity of responses to GABA signals across the brain and the organism, facilitating the numerous biological processes in which GABAA receptors are involved.

Despite the complexity and biological significance of GABAA receptors, recent reviews on their electrophysiology are missing. In this review, we summarize the current knowledge on the electrophysiology of the different GABAA receptor subtypes and show how their properties explain the role they play in cellular and cerebral activity. We mainly focus on mammals and on neuronal GABAA receptors. Related subjects such as GABAA receptor pharmacology or pathology will not be covered in this review; other reviews have already been published about pharmacology [1120], the regulation of subunits gene expression [2123], subunit intracellular trafficking [24, 25], non-neuronal GABAA receptors [2629], and pathology [3032].

Diversity and structure of GABAA receptors

GABAA receptor subunits diversity

Mammals have 19 genes coding for a GABAA receptor subunit, classified in classes (α, β, γ, ρ, θ, ε, π and δ) and isoforms (α1–6, β1–3, γ1–3 and ρ1–3) [33, 34]. The diversity of subunits is further increased by alternative splicing, to which 9 out of 19 subunits are submitted [34, 35]. Alternative splicing enables the β2, γ2, γ3 and ρ1 subunit genes to produce at least two mature proteins, but differences in receptor activity depending on alternative splicing have been reported only between the γ2L and γ2S isoforms of the γ2 subunit; the main function of alternative splicing is believed to be the regulation of subunit expression [34].

Hundreds of millions of years ago, duplications of an ancestral gene led to the emergence of the different classes of subunits, and later to the different isoforms of a same class. The amino acid identity rate between isoforms of the same class ranges between 70 and 80%, whereas it typically lies between 30 and 40% for subunits of different classes [36].

Most subunits have remained very stable in the last tens of millions of years of vertebrate evolution. For example, the amino acid identity rate between mouse and human ortholog subunits is above 90% (except ρ3, with 84% identity). The conservation is not only structural but also functional: crustacean β subunits have been shown to functionally replace human β subunits in chimeric receptors [7, 37]. Likewise, deletion of a single GABAA receptor subunit often results only in a mild pathology or no phenotype at all [3842], showing that different subunits can substitute each other. These facts highlight the strong selective pressures applied on GABAA receptors, and suggest it has a substantial biological importance.

Subunits assemble into receptors whose structure is finely regulated

Mature subunits are integral plasma membrane proteins. Human subunits are 420–632 amino acid long and weigh between 52 and 59 kDa [34, 36]. They contain an extracellular N-terminal segment of 220–250 residues, which can be glycosylated; 4 transmembrane domains termed M1, M2, M3 and M4; and a short extracellular C-terminal segment (Fig. 1a).

Fig. 1.

Fig. 1

GABAA receptor structure and gating. a Structure of an isolated GABAA receptor subunit and of a mature receptor. Five subunits, potentially belonging to different classes or isoforms, assemble into a channel permeable to chloride and bicarbonate ions. Ions flow through GABAA receptors down their electrochemical gradient. b Control of GABAA receptor conductance by the receptor conformation. The central pore can be either closed or open as a result of agonist fixation on the receptor. In this example, the receptor is viewed from the extracellular space and the subunits are ordered as in the most abundant subtypes, namely αβγ. The presence of two GABA binding sites corresponds to ternary receptors (composed of subunits from three different classes)

A functional receptor contains five subunits (Fig. 1a), assembled in a circle around a chloride-permeable pore delineated by the M2 transmembrane domain of all five subunits [8]. Each monomer is thus in contact with two other subunits, respectively at its “principle”, or + , and “complementary”, or −, faces.

The study of structure–function relationships of GABAA receptors has long been hindered by the substantial diversity of conformations, making it difficult to stabilize a receptor population in a single state [43], and cryo-EM structures of GABAA receptors were only recently resolved (reviewed in [44]). GABA-binding sites are located at interfaces between subunits on the surface of the extracellular part of the receptor. GABA binding induces a conformation change, typically when all binding sites are occupied, through a concerted rotation of the extracellular domains of the five monomers [45]. This rotation is translated to the transmembrane domains and results in variations of the opening of the central pore (Fig. 1b). Based on models of GABAA receptor structure, Rossokhin predicted that the diameter of the channel pore is mainly controlled by residues—2′, 9′ and 20′ of the M2 transmembrane domain [46]. The ring formed by the 9′ M2 residues of the five subunits is termed activation gate. In the main closed conformation, the diameter of the ring is only 2.5–3.4 Å. GABA-induced conformation change prompts the side chains of the activation ring residues to shift away from the central pore, whose diameter increases up to 3.4–7.6 Å, allowing ions to flow through the channel.

The most frequent subunit composition of GABAA receptors is 2 α, 2 β and 1 γ subunit [47, 48]. In this case, the 2 α and 2 β subunits in the receptor are most often, but not always, of the same isoform [4853] and the receptor carries two GABA binding sites [54] located at the β+/α− subunit interfaces [44]. However, other stoichiometries can be observed [55]: ε, π and δ subunits can replace a γ subunit, and a θ subunit can replace a β subunit [33]. In addition, binary receptors (receptors containing two different classes of subunits instead of three, such as the αβ subtypes) are able to assemble in vitro. They were also described in vivo, but the evidence of their existence often comes from indirect methods [56] or study of γ2 or δ deficient mice [57, 58]: it is therefore possible that they are artefactual or accidental.

ρ subunits usually assemble in homopentamers or heteropentamers [59, 60], with five GABA binding sites per receptor [54], i.e. one at each subunit interface. However, in rare cases, ρ subunits assemble with α1 and/or γ2 subunits [61, 62].

GABAA receptors are classified into hundreds of subtypes

Due to the substantial subunit diversity, there are numerous subtypes of the GABAA receptor, characterized by the combination of subunits they contain (e.g. α1β2γ3) [6].

GABAA receptors are expressed in numerous cell types, most notably in neurons. The expression patterns of the different subunits determine which subtypes are assembled, as well as their cellular and subcellular location and their abundance. Numerous cells coexpress multiple GABAA subunits isoforms [4853]. Consequently, a single cell can express several GABAA receptor subtypes [56, 63, 64].

The most abundant subtype in the mammalian nervous system is α1β2γ2, possibly accounting for 60% of all GABAA receptors [65]. The other major subtypes are α2β3γ2 and α3β3γ2 [66], while α4–6βγ2, α6β2–3δ, α4β2–3δ and ρ1–3 are less abundant. Minor subtypes whose physiological existence in vivo is deemed likely include α1βδ, α2β1γ1, αβε, αβπ, αβθ, α1α6βγ2, α1α6βδ and αβγ3 [10, 66]. Though it is unlikely that all possible subunit combinations exist and assemble into functional receptors, the large number of possible combinations of subunits expressed by a given cell explains that the number of existing functional subtypes is estimated to be as high as 500 [9]. Most of these subtypes are expected be very rare compared to the most abundant ones [66] and to be limited to a specific tissue, brain area or developmental phase, but they may still exert non-neglectable effects on brain function because of the high abundance of GABAA receptors compared to most neuronal receptors [9] and because rare subtypes can be selectively enriched in certain neurons or synapses [12].

GABAA receptor ion conductance selectivity

GABAA receptors are ion channels. Different ions can flow down their electrochemical gradient through the pore from one side of the membrane to the other, generating currents. The intensity, i.e. the net charge transfer per time unit, of a transmembrane ion current is the product of the ionic electrochemical gradient by the number and conductance of open channels.

dqdt=I=NopenionsΔEionGion. 1

Nopen is the number of open channels at the considered membrane; it depends on numerous parameters, notably GABA concentration. For each ion, ΔEion designates the cognate transmembrane electrochemical gradient and Gion the conductance of a single open GABAA channel.

The conductance of GABAA receptors varies widely for different ions: we will study in this paragraph how this selectivity shapes the currents mediated by GABAA receptors.

GABAA receptor chloride conductance

In most circumstances in the adult brain, K+ coupled secondary active Cl transporters [67] generate an outwardly directed chloride electrochemical gradient at the neuron plasma membrane [68]. Consequently, GABA-induced opening of GABAA receptors induces a chloride influx (Fig. 1a), thus a hyperpolarization of the plasma membrane and an inhibition of action potential generation. This is the most frequent mechanism of inhibitory neurotransmission, which occurs in a large proportion of brain synapses.

However, during development [69], GABAA receptors mediate chloride efflux due to an inverted electrochemical gradient [70], and thus often activate the neuron [7073]. Such a mechanism has also been observed in slices prepared from adult brains [74], but these findings have been questioned because neurons in slices seem to have a higher intracellular chloride concentration than in vivo. This artifact may produce a non-physiological inversion of the chloride electrochemical gradient [75].

Membrane resistivity (ρ) is equal to the transmembrane potential (ΔE) divided by the intensity (I) of the current passing through a unit of membrane surface: ρ = ΔE × S/I (where S is the area of the membrane domain). The lower the resistivity is, the more intense is the transmembrane current generated by a given voltage gradient. The opening of channels, regardless if they mediate depolarizing or hyperpolarizing currents at the resting membrane potential, decreases membrane resistivity and promotes the dissipation of action potentials, a phenomenon termed shunting inhibition. Indeed, it enables ions to respond to the electrochemical gradient created by the action potential with local transmembrane flows instead of the expected longitudinal flows that are necessary for propagating the action potential to other membrane locations. Depolarizing currents mediated by GABAA receptors can interfere with action potentials propagation through shunting [76] or inactivation of voltage-dependent Na+ channels [77], and can thus be inhibitory instead of excitatory [78, 79]. Conversely, hyperpolarizations mediated by GABAA receptors may result in neuronal activation through rebound spikes [80, 81].

The GABAA receptor-mediated depolarizations observed during development can induce an influx of calcium through voltage-dependent channels [80, 82], favoring neurite outgrowth [83], synaptogenesis [84], neuron migration [85], and neuron survival [86].

Permeability of GABAA receptors to ions other than chloride

Although chloride ions account for most of GABAA receptor conductance in vivo [3], GABAA receptors are also permeable to bicarbonate, formate, propionate, acetate, cyanide and halides [3, 4, 87]. Differences in GABAA receptor conductance and permeability to these anions are caused by a selectivity filter relying on recognition sites [3] and the limited pore diameter.

Because of CO2 production and conversion in HCO3 inside the cell, bicarbonate flows mediated by GABAA receptors are outwardly directed (Fig. 1a), and thus depolarize the cell membrane. In standard physiological conditions, the ratio of HCO3 vs Cl permeability of GABAA receptors is comprised between 0.2 and 0.3 [88], i.e. chloride currents have a greater amplitude than bicarbonate currents and the net effect is hyperpolarization. However, prolonged GABA exposure can occasionally turn hyperpolarizing currents into depolarizing ones [89], notably during epileptic seizures or in hypothalamic hamartoma neurons [90]. This phenomenon probably indicates a dissipation of the chloride gradient [91, 92] when the channel remains open for long periods. Under these conditions, the bicarbonate efflux may become larger than the chloride influx and GABAA receptors may transiently become excitatory [72].

Intrinsic electrophysiological parameters of the different GABAA receptor subtypes

The impact of GABAA receptors on cellular electrophysiology mostly depends on the time-course and amplitude of the chloride currents evoked by exposure to an agonist such as GABA. Typically, the current time-course following the introduction of an agonist in the receptor’s environment consists of an initial current peak, followed by a decrease in amplitude (Fig. 2a). This decrease ends with a stabilization at lower amplitude or a complete closure of the receptors, depending on agonist concentration, duration of exposure to the agonist, and on the receptor subtype. The effects of GABAA receptors on neuronal activity are determined primarily by the charge transfer (the product of the current intensity with its duration) [93], but also by its synchronization with other electrical inputs, hence the importance of the shape of the current time-course [94, 95]. The current intensity at a certain time point is the product of the conductance of a single channel by the chloride electrochemical gradient and the number of open receptors (Eq. 1), which depends on kinetic parameters governing channel gating as well as receptor and agonist concentrations. Indeed, the effects of an agonist are dose-dependent: for example, the proportion of open receptors as a function of the GABA concentration follows an allosteric pattern (Fig. 2b), characterized by a concentration threshold at which the proportion of open receptors sharply increases.

Fig. 2.

Fig. 2

General characteristics of GABAA receptor-mediated currents. a Typical GABAA receptor current time-course and kinetic electrophysiological parameters. b Dependence of GABAA receptor-mediated current intensity on agonist concentration for different Hill coefficients

In most physiological situations, the cell response to a GABA input is driven by the joint action of dozens or hundreds or receptors that perceive the signal. The macroscopic scale (receptor populations) therefore appears more suited than the microscopic scale (single channels) to understand the biological consequences of GABAA receptor electrophysiology and is easier to study, which explains that most available information on GABAA receptor electrophysiology covers macroscopic features. Nevertheless, macroscopic properties always emerge from the integration of single channel activity characteristics.

The electric activity of GABAA receptors can be understood with a series of parameters that describe and explain their responses to the various patterns of agonist exposure. In this section, we will describe the macroscopic electrophysiological parameters that determine the activity of populations of GABAA receptors in response to GABA, and we will highlight the differences between subtypes in that regard.

Electrophysiological parameters can be subdivided into kinetic parameters (activation time, desensitization time, deactivation time…) and so-called functional parameters (conductance, EC50, Hill coefficient…), which describe respectively the current time-course and its dependence on agonist concentration. As will be exemplified below, some of these parameters are not independent.

Tools for the study of GABAA receptor electrophysiology

Before detailing the electrophysiological parameters of GABAA receptors, we will discuss two conceptual tools that were instrumental in the discovery and understanding of these parameters: modeling and the use of channel modulating drugs.

Modeling

Numerous models have been used to interpret the growing amount of data on GABAA receptor electrophysiology, predict receptor activity, and understand the microscopic origin of macroscopic parameters and large-scale behavior of channel populations.

Most of the models used are Markovian. Markovian models are discrete (time is discontinuous) and memory-free: the next step of evolution of a model depends only on its present state, and not on past states. Markovian models describe the activity of a channel with a series of states, each of them having its own conductance and being supposed to correspond to a specific receptor conformation. Transition rates can be a function of environmental parameters such as transmembrane potential or agonist concentrations. Transition rates indicate the kinetics of channel activity as well as states occupancy at equilibrium. For example, in the model showed in Fig. 3a, if p is the proportion of receptors in the open state at a given time point, a proportion pkc of the receptor population transitions to the closed state before the next time point, while a proportion (1 − p)ko of receptor transitions to the open state. At equilibrium, the net flux is null, meaning that pkc = (1 − p)ko, and therefore p = ko/(kc + ko).

Fig. 3.

Fig. 3

Markovian models of receptor channel activity. a Simplest Markovian model of a receptor channel, with two unitary states: open (O) and closed (C). The transition rates describing channel opening and closure are respectively ko and kc. Both transition rates are a function of the agonist concentration [A]. b Application of the two-states model to steady-state situations. K is the equilibrium constant, and depends on agonist concentration. c MWC model. L, r and K are constants depending on receptor structure and [G] is the GABA concentration. The open states are O (no GABA bound), OG (one GABA) and OG2 (two GABA); likewise, C, CG and CG2 are the close states

Certain models specifically describe systems at equilibrium. This simplification allows the replacement of transition rates by equilibrium constants. In our example model, the equilibrium constant K would follow the equation K = peq/(1 − peq) = ko/kc (Fig. 3b).

The most classic model used to describe GABAA receptor activity is the Monod–Wyman–Changeux two-state concerted transition model (MWC) [96]. This equilibrium model takes into account one open and one closed conformations, both of which can be bound to zero, one or two GABA molecules (Fig. 3c). The MWC model requires only four parameters to entirely describe the receptor response to an agonist, which explains its attractiveness. It accurately describes GABAA activity at the macroscopic scale, and its activation by numerous agonists and combination of agonists [47, 9698]. This model has confirmed the presence of two GABA binding sites on ternary receptors [97].

Other models (Table 1) complexify the MWC model to fit more accurately to certain experimental data, such as the flip model, which includes a transient pre-sensitized closed conformation with high agonist affinity [96, 99]. More complex models [100104] consider a greater number of states. Although generally more accurate than simpler models, complex models often lack predictive value since it is difficult to accurately estimate all the parameters of the model [96].

Table 1.

Examples of Markovian steady-state models used for GABAA receptor study

Model States Conditions of application
MWC Close, open (both bound to 0, 1 or 2 GABA) Macroscopic scale
Flip model Resting, resting bound to GABA, pre-sensitized bound, open bound Macroscopic scale
Resting-activated-desensitized Resting, open, desensitized (all bound to 0, 1 or 2 GABA) Desensitizing receptors
Chang and Weiss model Close (bound to 0–3 GABA), open ρ-Containing receptors

Complex models usually stem from the study of single channels, whose complex behavior requires several states to be accurately described, whereas fewer states are necessary to describe the properties of GABAA receptors activity at the synaptic or cellular scale. Despite the likely existence of several conformations, the two-conformations MWC models provide accurate predictions at a macroscopic scale. This indicates that the receptor conformations can be separated into two groups with minor electrophysiological differences within each group [96, 105], or that some of them are occupied only transiently and are not involved in the steady-state circumstances that the MWC model is used to describe.

Electrophysiological parameters can be calculated as a function of transition rates and state occupancies in certain models. Modeling also helps to understand the interdependence between parameters, or to calculate parameters inaccessible to direct experimentation. For example, Chang and Weiss [106] estimated that ρ-containing receptors open when they bind GABA in at least 3 of their 5 binding sites.

Channel modulating drugs

The activity of GABAA receptors is modulated by subtype-selective agonists and antagonists belonging to different chemical families such as benzodiazepines or barbiturates and including anesthetic, anxiolytic or antiepileptic drugs.

Since primary and transfected cells can often express several subtypes simultaneously, it is necessary to distinguish from which subtype come the currents measured during electrical recordings. Subtype-selective channel modulating drugs facilitate in situ subtype identification [10].

For example, Lindquist and Birnir performed a patch-clamp single-channel study of GABAA extrasynaptic receptors on dentate gyrus granule neurones and identified three types of electrophysiological signatures [107]. Receptors of the first, second and third type were potentiated respectively by zolpidem, flumazenil and THDOC, indicating that they belong respectively to α1βγ2, α4βγ2 and αβδ subtypes.

Channel modulating drugs have also been used to study GABAA receptors structure and to map subtypes expression in the brain. The benzodiazepine molecules [3H]Ro15-4513 and diazepam bind respectively all γ-containing subtypes and α1,2,3,5βγ receptors. Hence, under competition from diazepam, [3H]Ro15-4513 binds only α4,6βγ subtypes. Using this property, Korpi et al. mapped α4,6βγ receptors by autoradiography of [3H]Ro15-4513 in mouse brains and showed that they were overexpressed in δ−/− mice [108]. This proved that γ subunits can partly substitute δ.

Etomidate is a general anesthetic binding GABAA receptors on their GABA binding sites and potentiating their response to GABA. This potentiation involves comparable allosteric shifts between αβδ and αβγ subtypes, showing that αβδ subtypes carry two GABA binding sites as had been previously described for αβγ subtypes [109].

Kinetic parameters

Activation time

The delay between a change in GABA concentration and channel response varies between receptor subtypes [110]. The channel opening occurs in two phases: first, agonists bind to the receptor; second, the receptor conformation changes and the central pore opens. Thus, the delay in GABAA receptor opening upon GABA introduction in its environment depends both on GABA binding kinetics [111] and on the kinetics of receptor conformational change upon GABA fixation [111]. GABA fixation kinetics is determined by GABA concentration [75, 100, 105], following an allosteric pattern [112], and by the receptor affinity for GABA. At a given GABA concentration, the characteristic time of the GABA binding kinetics is theoretically inversely proportional to the receptor affinity for GABA: this relation has been observed in β2γ2S-containing subtypes [75]. However, at saturating GABA concentrations (in the order of 10 mM [112]), the conformational change kinetics becomes the limiting factor. This may explain why the δ subunit lowers the reactivity of the receptor compared to γ2 [113] despite a higher affinity. The activation time, i.e. the time to go from 10 to 90% of open channels after introduction of GABA, is 0.46 ms for α1β3γ2L at a GABA concentration of 1 mM, versus 2.4 ms for α1β3δ [114].

The activation times provided in Tables 2, 3 and 4 are calculated at saturating GABA concentration, thus should reflect the kinetics of conformation transition. In association with β3 and γ2L subunits, the rank order of α subunits in terms of activation time is α1 < α2 < α4 < α6 < α5 < α3, with α3 being three times slower than α1 [110112, 114]. However, when associated with β1 and γ2, α2 confers an activation twice faster than α1 [100]. αβ subtypes [115], and even more ρ-containing subtypes [116], display an extremely slow activation time lasting several tens of milliseconds. Receptors containing the ε subunit display slow activation in vivo [117]. However, this property has never been studied with recombinant ε-containing receptors, thus it may be conferred by another subunit.

Table 2.

Main electrophysiological parameters of the different GABAA receptor subtypes in standard ionic conditions (subunits expressed in Xenopus oocytes)

GABAA receptor subtype Single-channel conductance (pS) GABA EC50 (µM) Hill coefficient Characteristic time of desensitization td (s) Characteristic time of deactivation (ms) Activation time (ms)
α1β1γ1 1.2 [167]
α1β1γ2 30 [100]

4.5 [167]

6 [100]

1.2 [100]

0.492 [100] ([GABA] = 1 mM)

0.6 [103] ([GABA] = 100 µM)

20.5 [100]

17.4 [103]

1.1 [100]

1 [103] (γ2S splice variant)

α1β1γ3 0.6 [167]
α1β2γ1 0.67 [167] (human γ1, rat α1 and β2, expressed in 293 cells)
α1β2γ2

32 [152]

27.9 [56] (γ2S splice variant)

5 [172]

7 [110] (γ2S splice variant)

1.71 [177]

1.6 [110] (γ2S splice variant)

2.12 [152]

1.4 [110] (γ2S splice variant) 220 [110] (γ2S splice variant)
α1β2γ3 30.2 [178] 1.3 [167]
α1β2δ 6.71 [179]
α1β3γ1 2.1 [167]
α1β3γ2

28 [56] (γ2S splice variant)

27.5 [180]

1.7 [167]

2.9 [151] (γ2S splice variant)

7.6 [181] (γ2L splice variant)

14 [112] (γ2L splice variant)

36.2 [158] (γ2L splice variant)

14.1 [122] (γ2L splice variant)

1.7 [158] (γ2L splice variant)

0.424 [111] (average of 1 and 3 mM of GABA, γ2L splice variant)

0.95 [112] (γ2L splice variant, 1 mM of GABA)

68.6 [111] (γ2L splice variant)

143 [112] (γ2L splice variant)

82.5 [122] (γ2L splice variant)

0.55 [101] (γ2L splice variant)

0.603 [111] (γ2L splice variant)

α1β3δ 27.5 [180] 7.4 [181]

63.4 [181]

86.8 [123]

α2β1γ2 30 [100]

17 [184]

37 [100]

1.8 [100] 0.449 [100] ([GABA] = 1 mM)

198.7 [100]

82 (type 1) or 51 (type 2) [103]

0.5 [100]

0.5 [103] (γ2S splice variant)

α2β1ε 11.2 [185]
α2β2γ2 1.47 [177]
α2β3γ2 5.2 [151] (γ2S splice variant) 0.391 [111] (average of 1 and 3 mM of GABA, γ2L splice variant) 110.6 [111] (γ2L splice variant) 0.735 [111] (γ2L splice variant)
α3β1γ2 15.1 [167] (human α3, rat γ2 and β1, expressed in 293 cells)
α3β2γ2

130 [187]

15.1 [167] (human α3, rat γ2 and β2, expressed in 293 cells)

75 [110] (γ2S splice variant)

2.21 [177]

1.5 [110] (γ2S splice variant)

1.1 [187]

3.2 [110] (γ2S splice variant) 680 [110] (γ2S splice variant)
α3β3γ2 48 [151] (γ2S splice variant) 0.701 [111] (average of 1 and 3 mM of GABA, γ2S splice variant) 188.8 [111] (γ2L splice variant) 1.788 [111] (γ2L splice variant)
α4β1γ2 1.40 [177]
α4β1δ

0.30 [188]

0.17 [177]

1.57 [188] 174 [177]
α4β2γ2

3.9 [189]

1.4 [167]

α4β2δ 0.25 [179]
α4β3γ2

7.6 [151] (γ2S splice variant)

15 [112] (γ2L splice variant)

0.408 [111] (average of 1 and 3 mM of GABA, γ2L splice variant)

0.711 [112] (γ2L splice variant, 1 mM of GABA)

24.8 [111] (γ2L splice variant)

109 [112] (γ2L splice variant)

0.951 [111] (γ2L splice variant)
α4β3δ 0.35 [188] 1.8 [188]
α5β1γ2 5.6 [167]
α5β2γ2

5.8 [187]

4.2 [167]

0.47 [177]

1.5 [187]
α5β2γ3 4.9 [190] 1.9 [190]
α5β3γ2 24.9 [180] 11.6 [151] (γ2S splice variant) 1.315 [111] (average of 1 and 3 mM of GABA, γ2L splice variant) 41.5 [111] (γ2L splice variant) 1.247 [111] (γ2L splice variant)
α6β1γ2 0.5 [167]
α6β2γ1 0.4 [167]
α6β2γ2

5.2 [156] (γ2S splice variant)

1.4 [189]

0.34 [172]

0.50 [179] (γ2S splice variant)

α6β2δ

0.52 [156] (γ2S splice variant)

1.2 [167]

0.21 [179]

α6β3γ2 1 [151] (γ2S splice variant) 0.596 [111] (average of 1 and 3 mM of GABA, γ2L splice variant) 163.8 [111] (γ2L splice variant) 1.052 [111] (γ2L splice variant)
α6β3δ 340.4 [123]
ρ1 1.7 [116] 3.5 [116] 14.5 [116] (30 µM of GABA) 154 [116]
ρ2 2.6 [116] 3.3 [116] 8.2 [116] (30 µM of GABA) 180 [116]

Roman: rat subunits; bold: human subunits; bold italics: mouse subunits. The Hill coefficient, GABA EC50, main conductance state and characteristic times of activation, deactivation and desensitization of the most abundant subtypes in vivo, i.e. ternary subtypes and ρ homopentamers, are presented. Information on other subtypes can be found in [13, 103, 112, 114, 116, 123, 125, 130, 146, 152157, 176, 180, 182, 191, 192]

Table 3.

Main electrophysiological parameters of the different GABAA receptor subtypes in standard ionic conditions (subunits expressed in mouse L929 cells)

GABAA receptor subtype Single-channel conductance (pS) GABA EC50 (µM) Hill coefficient Characteristic time of desensitization td (s) Characteristic time of deactivation (ms) Activation time (ms)
α1β1γ1 5.2 [165]
α1β1γ2

30 [125] (γ2L splice variant)

29.3 [145] (γ2S splice variant)

7.1 [146]

5.2 [168] (γ2L splice variant)

5.1 [169] (γ2L splice variant)

6.2 [125] (γ2L splice variant)

1.7 [146]

1.9 [168] (γ2L splice variant)

1.9 [169] (γ2L splice variant)

1.4 [125] (γ2L splice variant)

5 [125] (γ2L splice variant)

6.0 [145] (γ2S splice variant)

α1β1δ 22 [125] No desensitization observed [125] 400 [125]
α1β2γ2 29 [145] (γ2S splice variant) 11 [171]
α1β3γ2

25.9 [114]

26.8 [130]

14 [171]

11.6 [130] (γ2L splice variant)

15.5 [111] (γ2L splice variant)

15.5 [182] (γ2L splice variant)

1.48 [111] (γ2L splice variant)

1.5 [182] (γ2L splice variant)

0.462 [114] ([GABA] = 1 mM, γ2L splice variant) 76.1 [114] (γ2L splice variant) 0.46 [114] (γ2L splice variant)
α1β3δ

23.8 [114]

26.7 [130]

2.8 [130]

4.4 [182]

1.4 [182] 1.26 [114] ([GABA] = 1 mM) 42.8 [114] 2.4 [114]
α1β3ε 24 [161] (rat α1 and β3, and human ε, in L929 cells) 0.8 [161] (rat α1 and β3, and human ε, in L929 cells) 0.9 [161] (rat α1 and β3, and human ε, in L929 cells)
α2β3γ2 25 [111] (γ2L splice variant)
α3β3γ2 35.8 [111] (γ2L splice variant)
α4β3γ2

10.7 [111] (γ2L splice variant)

2.57 [113]

1.3 [113] 2.5 [113] ([GABA] = 100 µM)
α4β3δ 0.5 [113] 1.3 [113] 4.8 [113] ([GABA] = 100 µM)
α5β1γ2

32.8 [157] (γ2L splice variant)

26 [124] (γ2L splice variant)

1.69 [157] (γ2L splice variant)
α5β3γ2 22 [133] (γ2L splice variant)

5.7 [157] (γ2L splice variant)

6 [124] (γ2L splice variant)

9.4 [111] (γ2L splice variant)

1.54 [157] (γ2L splice variant) 51.8 [133] (γ2L splice variant) 0.9 [133] (γ2L splice variant)
α5β3γ3 26.9 [191] 1.5 [191] 1.6 [191]
α5β3π 23.8 [191] 1.3 [191] 1.4 [191]
α6β2γ2 2 [171]
α6β2δ 0.2 [171]
α6β3γ2

2 [171] (γ2L splice variant)

2.25 [111] (γ2L splice variant)

1.04 [111] (γ2L splice variant)
α6β3δ 0.3 [171]

Roman: rat subunits; bold: human subunits; italics: bovine subunits. The Hill coefficient, GABA EC50, main conductance state and characteristic times of activation, deactivation and desensitization of the most abundant subtypes in vivo, i.e. ternary subtypes and ρ homopentamers, are presented. Information on other subtypes can be found in [13, 103, 112, 114, 116, 123, 125, 130, 146, 152157, 176, 180, 182, 191, 192]

Table 4.

Main electrophysiological parameters of the different GABAA receptor subtypes in standard ionic conditions (subunits expressed in Xenopus oocytes)

GABAA receptor subtype GABA EC50 (µM) Hill coefficient
α1β1γ1

25 [163]

41 [164]

75 [166]

α1β1γ2

9.8 [170] (γ2S splice variant)

19.9 [126] (γ2S splice variant)

1.36 [126] (γ2S splice variant)
α1β1δ 4.9 [170]
α1β1ε 4.0 [126] 0.85 [126]
α1β2γ2

41 [153]

16 [132] (γ2L splice variant)

45.8 [47, 173, 174]

34 [97] (γ2L splice variant)

55 [175]

20 [155]

20 [163]

4.61 [176] (γ2L splice variant)

1.39 [153]

1.59 [174]

1.57 [47, 173]

1.38 [97] (γ2L splice variant)

1.4 [175]

1.38 [176] (γ2L splice variant)

α1β3γ2 8 [163]
α2β1γ1 39.8 [183]
α2β1γ2 30.6 [183]
α3β1γ1 114 [163]
α3β1γ2

240 [154]

208 [163]

200 [186] (γ2S splice variant)

98 [164]

α3β1γ3 32 [163]
α3β1ε 2.3 [186]
α3β1θ 81 [186]
α3β2γ2

487 [154]

11 [163]

α3β3γ2 28 [163]
α5β1γ2

17 [154]

15 [163]

α5β2γ2 14 [154]
α5β3γ1 24 [163]
α5β3γ2 3 [163] (γ2L splice variant)
α5β3γ3 2 [163]
α6β2γ2

6.7 [153]

1.6 [155]

0.82 [153]
ρ1 0.81 [106] 2.83 [106]
ρ2 1.19 [162] 2.17 [162]

Roman: rat subunits; bold: human subunits; italics: bovine subunits; bold italics: mouse subunits. The Hill coefficient, GABA EC50, main conductance state and characteristic times of activation, deactivation and desensitization of the most abundant subtypes in vivo, i.e. ternary subtypes and ρ homopentamers, are presented. Information on other subtypes can be found in [13, 103, 112, 114, 116, 123, 125, 130, 146, 152157, 176, 180, 182, 191, 192]

The measured activation time depends on the size of the experimental settings. For example, macro-patches, in which several receptors gathered on a micrometric membrane domain are studied, display faster activation than whole-cell recordings [112]. It may be due to the time required for GABA to diffuse to all GABAA receptors, which is longer for larger experimental models, or to cytoplasmic proteins that may modulate GABAA receptor kinetics in whole-cell studies [112].

Desensitization

Upon long exposure to GABA, GABAA receptors lose their ability to open: this process is called desensitization (Fig. 2a). This mechanism is also observed when receptors are exposed to GABA transients at a high frequency and is then termed rundown (Fig. 4a) [118]. Desensitization prevents the transmission of abnormally strong inhibitory signals during synaptic communication: if GABA is chronically present in the synapse rather than by interspaced bursts, as it is under normal conditions, postsynaptic GABAA receptors will close [119].

Fig. 4.

Fig. 4

Characteristics of GABAA receptor desensitization. a Rundown. When GABAA receptors are exposed to frequent GABA transients, a portion of the receptor population desensitizes at each transient and does not recover before the next exposure, resulting in a decrease in peak amplitude. b Biphasic desensitization. The current decay upon desensitization can often be modeled as the sum of two decreasing exponential components. A global desensitization rate can be computed from the characteristic time (τ) of each component.

In desensitized conformations, the M2 transmembrane domains are tilted and their -2′ residues obstruct the intracellular end of the central pore of GABAA channels [46]. The five monomers constituting the channel can transition between open and desensitized conformations independently from one another [120].

During prolonged GABA exposure, the proportion of open channels sometimes follows a decreasing exponential curve over time [75], thereby a characteristic time of desensitization (td) can be calculated. In other cases, the observed desensitization curve can be described as the addition of several exponential components [112, 121, 122] (Fig. 4b). In this situation, a single td can be computed as the average of the characteristic times of each component weighted on the amplitude of the related current (this is the procedure followed to calculate the td shown in Tables 2, 3 and 4). Consequently, the calculated value of td depends on the duration of GABA exposure [111]. In long exposures, slow components gain in relative importance and the calculated td increases. In addition, td depends strongly on GABA concentration [75]: the curve of desensitization rate as a function of GABA concentration follows approximately an allosteric pattern. When enough data are available for calculations, the td presented in Tables 2, 3 and 4 are the asymptote of this curve at infinite GABA concentration.

The characteristic time of desensitization is usually in the order of 1 s, despite important variations. αβγ receptors containing the α4 subunit desensitize two to three times faster than those containing the α3 or α5 subunit, with α1 and α2 desensitizing almost as fast as α4, and α6 conferring an intermediary desensitization time [75, 111, 112]. However, when the receptor includes a δ subunit, α6 appears to confer faster desensitization than α1 [123]. β2 confers a slightly faster desensitization than β3, with β1 as an intermediate [124] or giving results similar to β2 [100]. Desensitization of γ2-containing receptors is two or three times faster than that of δ-containing receptors [113, 123, 125], but substantially slower than that of ε-containing receptors [126].

Certain subtypes do not desensitize or desensitize only partially. For example, homomeric ρ-containing receptors are almost insensitive to desensitization [5, 116, 127, 128]. Unlike γ-containing subtypes, receptors containing the δ subunit desensitize only partially [101]: α1β3δ currents decrease by only 11.6% upon 6 s exposure to saturating GABA concentration [123]. The α subunit plays a lesser but still notable role in determining the extent of desensitization (Table 5): γ-containing subtypes desensitize incompletely only if they contain the α3 or α5 subunit [111], with a steady-state current in prolonged GABA exposure of up to 30% of the peak amplitude. α1β3 receptors containing two α and three β subunits desensitize more extensively than receptors containing three α and two β subunits [129].

Table 5.

Properties conferred by the “first subunit class” of the receptor

isoform α1 α2 α3 α4 α5 α6
GABA EC50 Medium Medium Very high Medium Medium Very low
Desensitization Complete and moderately fast Complete and moderately fast Slow and incomplete Fast and complete Slow and incomplete Medium speed and complete
Refractory period Long Medium Medium Short Short Very long
Deactivation Moderately fast Moderately slow Very slow Very fast Fast Slow
Activation Fast Moderately fast Slow Medium Moderately slow Medium

Desensitization can be followed by a refractory period [114], during which receptors are unable to reopen. The length of this period is modeled as a function of several decreasing exponentials, indicating that GABAA receptors can adopt several closed conformations [114, 130], whose relative proportions depend on GABA concentration [130]. In vivo, the fast components of the refractory period disappear at low GABA concentration. In these conditions, desensitization is less extensive but its effects last longer [130, 131]. The length of the refractory period varies between subtypes, with receptors containing α4 or α5 being the fastest to recover (with a characteristic time of 25 ms following a 5 ms exposure to GABA), followed by α2 and α3 (about 100 ms), then α1 (about 200 ms) and finally α6 (about 400 ms) [111]. Nonetheless, characteristic times heavily depend on experimental procedures and method of calculation [112].

The study of desensitization prompted the development of complex, non-steady-state models of GABAA receptor activity since the MWC model does not describe receptor desensitization and therefore applies well only to non-desensitizing subtypes or to short time-frames of activation. These limitations are tackled by three-state models such as the resting-activated-desensitized model (Table 1) [132]. Other models describe the different components of desensitization or refractory periods with several desensitized states [114, 120, 133]; the desensitization times and durations of refractory period components are represented by the transition rates respectively to and from these states. Using one of these models, Gielen et al. [120] proposed that the fast component of desensitization corresponds to receptors with two of their five monomers adopting a desensitized conformation, while the slow component corresponds to receptors with at least three desensitized monomers.

Speed, extent and relative proportions of exponential components of desensitization are critical in shaping the time-course of the inhibitory post-synaptic current (IPSC) mediated by GABAA receptors and strongly differ between subtypes [102, 106, 114, 134, 135]. For example, α6β3δ has no fast component, unlike α6β3γ2L [101, 123]. Consequently, despite the similarity of the characteristic time of their slow component of desensitization, α6β3δ appears to desensitize less extensively than α6β3γ2L and is less sensitive to the duration of GABA exposure. As a result, α6β3δ transmits inhibitory signals whose intensity is roughly proportional to the duration of GABA exposure, while α6β3γ2L-mediated signals do not depend on exposure duration. This exemplifies that minor differences between subtypes at the microscopic scale can be amplified at larger scales. Furthermore, the time-course of IPSCs determines the strength and timing of neuronal inhibition, so limited differences in desensitization properties can have dramatic effects in the response of neuronal circuits to high-frequency inhibitory signals [101, 136].

Deactivation

GABAA receptors spontaneously release their ligands and close several milliseconds or tens of milliseconds after a drop in GABA concentration. The event of deactivation puts an end to the transmission of a hyperpolarizing signal during synaptic communication, after a brief GABA exposure (synaptic GABA bursts usually last no longer than a few milliseconds). Contrary to desensitized channels, deactivated channels can reopen without a refractory period.

Deactivation has been observed to be biphasic in vitro [100, 103, 111, 114, 122, 133] and in vivo [105, 137]; the relative proportions of the two components can vary depending on the receptor subtype. These two components may correspond to two conformations, one bound to two GABA molecules (the slow component) and the other to a single one (the fast component) [102], but this hypothesis is debated [114]. Deactivation can sometimes be triphasic [56], once again depending on the subtype and probably on recording procedures, because certain protocols do not enable the recording of very fast components [112].

Homomeric ρ-containing receptors deactivate quickly [116]. Among α-containing subtypes, those containing α4 are the fastest to close, followed by α5 (1.5 times slower), α1 (2.5 times slower than α4), then α2 (5 times slower than α4), and finally α6 (6 times slower than α4) and α3 (about 10 times slower than α4). The γ2 subunit confers a slower deactivation than δ [138, 139]. The β2 subunit confers a substantially faster deactivation than β3 [140].

Most studies on deactivation have been conducted on whole-cell or multichannel patches, which should give results close to what is observed in vivo at the synaptic or cell scale. However, deactivation is much faster in single-channel (0.2–25 ms) than in channel cluster or whole cell (5–680 ms) recordings [141, 142]. This discrepancy likely stems from sequential closing and opening events of a single channel (Fig. 5), which are integrated in a single current time-course by whole-cell or multichannel patches recordings [105, 143]. It exemplifies the apparent gap between the complex macroscopic properties of GABAA receptors and the single-channel activity they emerge from.

Fig. 5.

Fig. 5

Relationships between microscopic and macroscopic kinetics of channel opening. Deactivation is a macroscopic property resulting from the integration of single-channel currents time-courses. Its characteristic time (τ) is longer than mean channel open time due to possible channel reopening events and is increased by desensitization due to the possible reactivation of desensitized channels

The deactivation time increases in proportion with the extent of desensitization [102, 123, 135], maybe due to a high GABA affinity of desensitized states [135]. GABA is thus retained on desensitized or pre-desensitized receptors for tens of milliseconds, even when all GABA has been cleared from the extracellular space [144]. If the receptor is still bound to GABA when the refractory period ends, it is able to reopen immediately. When numerous receptors are considered together, this process results in a prolongation of the phase in which the current decreases, which is described as a slower deactivation (Fig. 5). Consequently, the fast components of desensitization prolong GABAA receptor responses to GABA and therefore synaptic communication while decreasing the current amplitude [102, 131].

Functional parameters

Conductance

A single GABAA channel can display several conductance states, remarkably conserved between species and cell types, ranging around respectively 12, 20, 30 and 45 pS for the most frequent subtypes. The main conductance state is 30 pS, meaning that this is the state adopted by the channel in most circumstances when it is open [4]. The conductance states may correspond to different channel conformations.

Most GABAA receptor subtypes display very similar conductance values (Tables 2, 3, 4) [145, 146]. However, the main conductance state of γ-containing receptors (~ 30 pS) [125] is higher than that of δ-containing receptors (~ 22 pS) [125], ρ-containing receptors (7 or 8 pS) [147, 148] and αβ binary subtypes (11–20 pS) [56].

GABA EC50

The curve of GABAA receptor peak current intensity as a function of GABA concentration follows an allosteric pattern (Fig. 2b), described by the equation of Hill:

IImax=[A]hEC50h+[A]h, 2

where I is the current intensity, Imax its asymptote at infinite agonist concentration, [A] the agonist concentration, and h the Hill coefficient (see “Hill coefficient”).

EC50 is the GABA concentration at which the current peak reaches 50% of its maximal amplitude. The EC50 partially reflects the receptor affinity for GABA: in general, the lower the EC50, the higher the affinity. However, the EC50 also depends on gating parameters such as the speed or maximal probability of channel opening. This can be exemplified by a simple stochastic model with a single binding site and a single opening state.

A+RKonKoffARβαAR, 3

where A is an agonist that binds to a receptor site R, A + R is the vacant state of the receptor site, AR the occupied state, AR* the open state, Kon and Koff, respectively the association and dissociation constants of the agonist, and β and α are respectively the opening rate and closing rate constants of the channel. In this model, the true affinity of the receptor for its ligand is the microscopic dissociation constant Kd = Koff/Kon. The receptor efficacy is defined as the equilibrium constant of the closed-open isomerization E = β/α. In this model, the apparent affinity EC50 verifies EC50 = Kd/(1 + E).

The receptor efficacy is related with Pomax, the maximum fraction of receptors in the active state, by the relation Pomax = E/(1 + E) = 1 − (EC50/Kd). Pomax can only be estimated at saturating GABA concentration using non-stationary noise analysis [149]. However, the presence of several open states can render the estimation of receptor efficacy very challenging. Hence, the true affinity and efficacy of GABAA receptors are often inaccessible to accurate measurements and the EC50 is used as a measure of the apparent affinity.

When certain receptors of a cluster open for the first time upon GABA exposure, others may be already closed, due to fast desensitization. It results in a smoothened shape of the current time-course through decreased peak amplitude and spreading of charge transfer over time. This phenomenon is stronger at high GABA concentrations, which explains why Pomax is often substantially inferior to 1 and EC50 is close to the true affinity Kd.

GABA EC50 is up to 100-fold lower than the concentration (termed BC50) at which the probability of occupancy of the GABA binding sites is equal to 0.5 [150], and than the concentration at which the half-maximal activation rate is reached [100, 112]. This discrepancy is explained by differences in GABA affinity between receptor conformations [106] and by the influence of desensitization on EC50, as confirmed by the small difference between EC50 and BC50 in the non-desensitizing ρ1 subtype [106]. It indicates that the EC50 is not a purely thermodynamic parameter but partially depends on receptor kinetics. Macroscopic parameters of GABAA receptor electrophysiology are complex and emerge from the interconnection of the numerous properties of single channels.

Significant differences in GABA EC50 can be observed between GABAA receptor subtypes, covering 2 orders of magnitude from around 0.5 µM to around 50 µM. Discrepancies are also observed for the same subtype in different studies, due to differences in the cell type where the receptor was expressed, in the species of origin of the receptor subunits or in experimental design (Tables 2, 3, 4). It nonetheless appears that the α subunit plays a crucial role in determining the receptor’s affinity for GABA (Table 5). The rank order of increasing GABA EC50 is α6 < α1 ~ α2 < α4 < α5 < α3 when these subunits are associated with β3 and γ2S [151], but α6 < α4 ~ α5 < α1 < α2 < α3 in association with β3 and γ2L [111]. The β isoform affects GABA affinity to a limited degree, with the β3 isoform conferring a one to fourfold lower GABA EC50 than β1 and β2 (Table 6). The γ1 subunit confers a higher EC50 than γ2 when these subunits are associated with α5, but in association with α3, the relationship is inverted. Several studies indicate a low EC50 in receptors containing the γ2S or γ3 subunits compared with the γ2L splice variant (Table 7). Receptors containing the δ subunit consistently display an EC50 around 5 times lower than γ2-containing receptors. ρ-containing subtypes are around 7 times more sensitive to GABA than the most abundant ternary receptors [147]. Subtypes containing two different isoforms of the same class generally show intermediate properties between the two corresponding subtypes containing only one of these two isoforms [125, 152157]. Binary receptors have a very low GABA EC50 [146, 158], around 1 µM, which is as low as the most GABA sensitive ternary receptors. Binary α1β3 receptors containing two α and three β subunits have a lower GABA EC50 than α1β3 receptors with three α and two β subunits [129].

Table 6.

Properties conferred by the “second subunit class” of the receptor

Isoform β1 β2 β3
GABA EC50 Medium Medium Moderate
Desensitization Medium Medium Moderately slow
Deactivation Medium Moderately slow
Table 7.

Properties conferred by the “third subunit class” of the receptor

Isoform γ1 γ2L γ3 δ ε π
Conductance Medium Medium Medium Low Low Medium
GABA EC50 Medium Medium (γ2L variant) or moderate (γ2S variant) Moderate Low Medium Moderate
Hill coefficient Medium Medium Medium Medium Low Medium
Desensitization Complete and moderately fast Slow and incomplete Fast
Deactivation Medium Moderately fast
Activation Fast Slow

Hill coefficient

The Hill coefficient of a GABAA receptor depends on its number of GABA binding sites and on cooperativity between GABA binding sites, the process by which the binding of GABA to one site increases the affinity or accessibility of the other site(s) for GABA. The higher the number of GABA binding sites or the extent of cooperativity are, the higher the Hill coefficient is. For Hill coefficients higher than 1, there is a threshold in GABA concentration where the opening probability of the receptor dramatically increases over a limited concentration span. The higher the Hill coefficient, the steeper the threshold (Fig. 2b).

In experimental systems with low temporal resolution, fast desensitization can decrease the resolution of the current peak, which might lead to errors in calculations of Hill coefficients. To the best of our knowledge, this phenomenon has not been tested with GABAA receptors, but it was described in the glycine receptor [159] which belongs to the same receptor superfamily as GABAA receptors.

Most GABAA receptor subtypes have very similar Hill coefficients of around 1.5. However, binary αβ receptors and ε-containing receptors display low cooperativity [126, 146, 160, 161] with Hill coefficients below 1. On the opposite, ρ-containing subtypes display higher Hill coefficients than the most abundant ternary receptors [106, 128, 162], probably due to the presence of 5 GABA-binding sites instead of 2 [54].

Subunits interplay in the integration of subtype-specific electrophysiologycal properties

Due to the remarkable evolutionary conservation of the sequence of GABAA receptor ortholog subunits, the electrophysiological properties of a certain subtype are expected to be similar in different species. To our knowledge, receptors of the same subtype but different species have never been compared in the same study. Tables 2, 3 and 4 highlight significant differences in the main parameters of certain subtypes between species, but important intraspecies differences are also observed, sometimes even when the subunits are expressed in the same cell line. Indeed, experimental procedures and measurement techniques can have a substantial influence on the results [112]: it can therefore be difficult to compare different subtypes. A further complication is that many authors did not distinguish between the splice variants γ2S and γ2L. Still, conclusions can be drawn by comparing subtypes studied in the same article with the same protocols or when several articles give very similar results on the same subtype.

The electrophysiological properties of a ternary subtype are mainly determined by the α subunit isoform and the class of its “third subunit class” (Table 5, 6, 7). Few differences are observed between β or γ isoforms. Some of the differences observed between β isoforms are thought to stem from their differential distribution and association with different isoforms of the α class. For example, preferential association of β3 with α2 and α3 instead of α1 is likely to explain the slower kinetics of the β3-containing subtypes as compared with the other β-containing subtypes [193]. Moreover, the electrophysiology of a subtype does not result in a straightforward manner from the addition of the properties conferred by its subunits because of the complex interactions between these subunits: the properties of a subunit depend on its environment within the receptor.

Binary αβ receptors display low GABA EC50, conductance and Hill coefficient, and activate slowly. In most cases, they desensitize slowly and not extensively, except the α1β3 subtype which desensitizes as fast and extensively as α1β3γ2L [114]. Despite substantial differences with ternary receptors, binary receptors helped to understand the molecular basis of ternary receptors electrophysiology. For example, using αβ2 subtypes, Olander et al. [115] showed that differences in activation and desensitization kinetics between α isoforms are determined by their transmembrane and intracellular domains. However, this study didn’t identify the cause of variations in deactivation kinetics, since the different αβ2 subtypes investigated didn’t differ significantly in that parameter. Similarly, the extent of desensitization of αβγ receptors was not matched by the corresponding αβ subtypes, with α1β2 desensitizing incompletely, contrary to α1β2γ. This confirms that novel properties emerge from the new subunits interactions introduced by γ or δ subunits in ternary receptors.

Receptors made of ρ subunits react very slowly to changes of GABA concentration, do not desensitize and deactivate quickly; they have low conductance and GABA EC50 but a high Hill coefficient.

The response of GABAA receptors to particular GABA inputs can be predicted from the parameters that have been described so far. For example, due to similar conductance, faster activation and slower deactivation, α2β1γ2 mediates tenfold higher charge transfers than α1β1γ2 when it is activated [100], but the higher GABA EC50 of the former means that stronger inputs are necessary to activate it.

Several studies found a great consistency between the electrophysiological activity of in vitro recombinant and in vivo endogenous GABAA receptors [60, 102, 103, 137, 152, 154, 194] (reviewed in [195]). The parameter values given above should therefore be relevant enough in physiological contexts to explain the activity and function of GABAA receptors in the nervous system.

GABAA receptors mediate different types of currents at the neuronal scale

As receptors of the most abundant inhibitory neurotransmitter, GABAA receptors are expressed in most neurons and influence their electric activity. Depending on the neuronal type, GABAA receptors can be located in the dendrites, the cell body and/or the axons. They are highly enriched at post-synaptic sites [194, 196], where they usually mediate inhibitory neurotransmission, but can also be found extrasynaptically and perisynaptically. Despite the preferential synaptic localization of α1, α2, α3, and especially γ2 [197], no GABAA receptor subunit has yet been found exclusively in synapses [196, 198]. Receptors containing the α4, α5, α6, γ1, γ3 or δ subunits, as well as binary αβ subtypes, are mainly extrasynaptic [56, 196, 197, 199], although the α4, α5 and α6 subunits can also be found in synapses at medium concentrations.

Due in part to the diversity in electrophysiology of the different subtypes, GABAA receptors mediate several types of currents in neurons. These currents, and by extension the subtypes involved in their generation, have different biological functions.

Phasic activity

Post-synaptic GABAA receptors primarily have a phasic activity: they mediate intense currents of regulated duration upon binding GABA molecules released in the synaptic cleft by the pre-synaptic neuron. Phasic receptors are involved in synaptic communication and are the main mediators of inhibitory signals [200]. The most abundant synaptic receptors of the mature brain belong to subtypes containing the γ2 subunit associated with β subunits and α1 or α2 [114, 201]. Their electrophysiological properties (see Tables 5, 6, 7) ensure the speed and specificity of inhibitory post-synaptic currents (IPSCs) generated in response to pre-synaptic GABA release, ensuring efficient neuronal communication. Indeed, the GABA concentration reaches 2-5 mM in the synaptic cleft during a GABA burst [134, 202], a concentration much higher than the EC50 of any GABAA receptor subtype (Tables 2, 3, 4). Low affinity receptors are thus activated by GABA bursts without being activated by background GABA concentration (Fig. 7a), which ensures that receptor activation is dependent on pre-synaptic inputs. The quick activation of most phasic receptors increases the speed at which neuronal networks communicate, and allows the receptors to respond to GABA bursts despite the extremely fast clearance of GABA in the synapse (whose time constant is only 0.3–0.6 ms) [134].

Fig. 7.

Fig. 7

Comparison of phasic and tonic currents. a Phasic current. 1: due to the high GABA EC50 of most phasic receptors, background GABA transients do not activate GABAA receptors. 2: fast activation. 3: high amplitude current peak. 4: slow deactivation. 5: rundown. b Tonic current. 1: slow activation. 2: steady-state, low-amplitude current with limited desensitization

The transmission of a strong inhibitory signal requires maximization of charge transfer. This is ensured by the high receptor concentration (there are usually tens to hundreds of receptors per inhibitory synapse) [56, 73] and the maintenance of the IPSC for relatively long times [102]. Indeed, the slow or intermediate deactivation of phasic receptors enables IPSCs to last several tens of milliseconds. In addition, slow deactivation is associated with fast and complete desensitization, which explains the common observation of IPSC depression upon high frequency stimulation, a phenomenon termed rundown (Fig. 4a) [203, 204]. This process protects neurons against pathological excessive inhibition in case of defective clearance of GABA, or excessive GABA emission in the synaptic cleft.

Different GABAA receptor subtypes can be located at different synapses of the same neuron. This phenomenon enables precise modulation of neurotransmission because identical signals received at different synapses will not induce the same phasic current in the postsynaptic neuron [196, 205, 206]. Several subtypes can even be expressed in the same synapse [207210]. In such a case, the post-synaptic current triggered by GABA is a composite of the currents mediated by the individual subtypes.

Ternary subtypes (αβγ or αβδ) and ρ-containing subtypes are coexpressed at the axon terminals of retinal bipolar cells [208, 210] and mediate different types of phasic currents: ternary receptors mediate fast and brief currents, whereas ρ-containing receptors mediate long and delayed currents that can be explained by their slow activation and lack of desensitization [211]. Since ρ-containing subtypes have the lowest GABA EC50 (Tables 2, 3, 4), it is possible that at low GABA concentration, only the slow and long currents take place. Therefore, the diversity of phasic receptors facilitates complex and diverse responses to GABA inputs in a dose-dependent manner [5, 212]. In retinal bipolar cells, the contribution of different GABAA receptor subtypes to the generation of inhibitory currents varies between cell subpopulations [213, 214], probably because of differences in abundance of the considered subtypes. Consequently, the IPSCs follow different times-courses in different cell subpopulations [215], leading to differences in cell function (reviewed in [5]). This exemplifies that the characteristics of an IPSC depend on the GABAA receptor subtype by which it is mediated and that different types of neurons can vary in their phasic activity as a consequence of different subtypes expression patterns (reviewed in [216]).

During development, phasic currents are longer and less intense than in the adult brain [56, 73, 200, 217]. Indeed, the α1 and α2 subunits are not yet expressed at high levels and most synaptic receptors belong to the α3βγ2 subtypes, which display very slow deactivation (Tables 2, 3, 4).

Sometimes, GABA escapes from a synapse (a process termed spillover) and reaches a nearby synapse. The micromolar GABA concentration in the receiving synapse induces a very faint IPSC, and desensitizes a portion of the GABAA receptors present there, which enter refractory periods that can last several seconds. If millimolar GABA bursts occur in the synapse before the end of the refractory period, the resulting phasic current will be diminished by rundown (Fig. 6) [131]. Since GABA bursts frequently occur in synapses, the net effect of spillovers is often excitatory despite the faint IPSC they directly induce. Spillovers are rare in physiological conditions in the adult brain since highly efficient GABA uptake systems usually ensure efficient clearance of GABA in synapses; however, these systems can be downregulated [218, 219].

Fig. 6.

Fig. 6

Effects of spillover on GABAA receptor-mediated post-synaptic currents. Phasic activity occurs upon the fixation of GABA by GABAA receptors on the post-synaptic neuron. Spillovers from nearby synapses can desensitize part of the receptors and decrease the amplitude of the next IPSC

Whether GABAA receptor-mediated currents are excitatory or inhibitory depends in certain circumstances on receptor location and timing relative to depolarizing signals [220, 221], hence the importance of the brevity and spatial confinement of phasic currents [198]. Phasic currents are brief and often induced at a single synapse, allowing them to regulate neuronal and cerebral activity very finely and to generate a substantial diversity of responses to similar inputs, in part due to GABAA receptor subtype diversity. Among other functions, GABAA receptor phasic activity is required in the generation of θ and γ frequency network oscillations, under strict temporal control [198].

Tonic activity

Certain GABAA receptors, mostly extrasynaptic, mediate chronic low-amplitude currents termed tonic currents [198]. Their activity is less temporally and spatially restricted than that of phasic receptors [198]. They are involved in long-run (seconds to minutes) modulation of neuronal activity and respond to GABA spillover or to non-synaptic release of GABA. They belong mostly to subtypes containing the δ subunit and the α4, α5 or α6 subunits [64, 114, 196, 222] or to ρ-containing subtypes [62], although certain γ2-containing subtypes can mediate tonic currents (reviewed in [201]). The characteristics of tonic activity are related to the electrochemical properties of the GABAA receptor subtypes involved [223]: these subtypes display a high affinity to GABA (Tables 2, 3, 4), allowing a response to low extrasynaptic GABA concentration; and a low conductance as well as incomplete desensitization, enabling channel groups to deliver limited but steady currents (Fig. 7b). Furthermore, the amplitude of current mediated by δ-containing receptors at saturating GABA concentrations can be multiplied up to 20 times by the agonist etomidate [109], showing that the maximal open probability in the absence of agonists Pomax of the concerned subtypes is no higher than 5%, and explaining the low amplitude of the tonic currents they mediate.

γ-containing subtypes desensitize extensively when exposed to high GABA concentrations, but the low GABA concentrations which elicit tonic activity may not desensitize them to such an extent as to abolish tonic currents [114, 195]. Deactivation does not hamper tonic activity, because GABA presence is maintained over long periods, allowing closed receptors to reopen; deactivation even ensures that tonic currents remain at a low amplitude. Finally, the slow activation of tonic receptors, caused both by low GABA concentrations and the electrophysiological properties of the subtypes involved, participates in shaping tonic currents. At subsaturating GABA concentrations, the current peak is truncated, resulting in stable currents reaching a steady state without going through sharp peaks after changes in GABA concentration [112].

Receptors that usually mediate phasic currents can at times display a low-level tonic activity, including in synaptic locations, due to a very low but strictly positive probability of opening at GABA concentrations close to zero [132, 224]. For example, even at standard extracellular GABA concentration, the amplitude of tonic currents through α1β2γ2L can reach 1% of the amplitude of phasic currents [224]. Moreover, it has been proposed that certain subtypes can mediate both phasic and tonic currents not only depending on their location or on GABA concentration, but also on whether both or only one of their two GABA-binding sites are occupied [175].

Tonic charge transfer can have a significant effect on neuronal communication: it has stronger inhibitory effects than phasic inhibition in certain neuron types such as cerebellar granule cells and hippocampal pyramidal cells [73, 200, 222, 225]. This demonstrates that the steadiness of tonic currents can compensate for their lack of intensity compared to phasic currents in generating a strong response [222].

Tonic activity has been predicted to have different effects than phasic activity on neuronal network activity, notably a decrease of rhythmicity and synchronicity between neurons [226, 227]. At a wider scale, models of cerebellar activity predict that tonic inhibition increases the number of motor patterns that can be stored in the cerebellum [228, 229].

During development, tonic activity is mainly activated by action potential-induced GABA release in the extracellular space [73, 200, 217]; however, non-vesicular and acetylcholine-induced, action potential-independent GABA release plays the major role in tonic inhibition in the adult cerebellum [137, 200]. This developmental transition can be related to the increasing wrapping of synapses by glial cells [230], which progressively prevents GABA spillover [200]. It is not only the source of tonic currents that varies during development, but also their amplitude. For example, tonic currents are detected in hippocampal pyramidal cells only in embryonic life [231], while they increase over time in cerebellar granule cells [73, 200]. Spatial discrepancies can also be caused by variations in extracellular GABA concentration between brain areas [225].

Tonic currents can modify the information conveyed by neurons [70, 232]. Unlike phasic currents, they do not determine the information conveyed by a single message but rather subtly modulate the information transmitted by the neuron over long time frames encompassing several communication events. Tonic inhibition is a form of regional-scale neuromodulation, offering a negative feedback to periods of intense synaptic activity during which successive spillovers increase the extracellular GABA concentration [198]. The long duration of tonic currents enables them to mitigate the oscillatory patterns often induced by phasic communication [226] and thus to desynchronize the activity of neighbor neurons [227].

Since the various tonic GABAA receptor subtypes differ in their EC50, slight increases in GABA extracellular concentration can progressively recruit a new receptor population. It widens the repertoire of potential tonic activity, since limited and finely regulated changes in GABA concentration can lead to the selective activation or inhibition of only part of the receptors mediating tonic currents [225].

Most transporters responsible for the clearance of GABA out of the extracellular space are unable to lower GABA concentration below 0.4 µM [233], a concentration higher than the EC50 of several α6-containing subtypes (Tables 2, 3, 4). Some receptors are thus continually activated and exert a function of leakage channel, as experimentally confirmed in the rat hippocampus [234]. Rather than being involved in the transmission of inhibitory signals, such receptors are believed to regulate membrane resistivity [78]. If this hypothesis is correct, these receptors control the time window over which synaptic integration occurs as well as the neuronal gain (the ratio between received and emitted currents), and thus the action potential firing rate [225, 232]. This exemplifies that the functions accomplished by a GABAA receptor subtype are determined by its electrophysiology.

Perisynaptic GABAA receptors

Perisynaptic GABAA receptors are activated by GABA spillover out of the synaptic cleft. They account for the slow-component inhibition of biphasic GABA-mediated response [235], a phenomenon in which the GABA released in a synapse first activates phasic post-synaptic receptors, then spills over in the extracellular space and activates perisynaptic receptors. GABA diffuses in a much greater volume in the extracellular space than in the synaptic cleft. Consequently, it reaches perisynaptic receptors with a delay compared to synaptic receptors and at a much lower concentration. Therefore, the biphasic GABA-mediated response consists of a localized, fast and intense phasic current followed by a diffuse, low-level and less cell-specific hyperpolarization. Perisynaptic receptors thus prolong phasic activity. They also take part in tonic inhibition [73] and spillover-mediated heterosynaptic modulation [232], whereby GABA spillover out of a synapse inhibits nearby neurons uninvolved in the considered synapse (reviewed in [236]).

Presynaptic inhibition

GABAA receptors can be found on the axons of certain neuron types, where they sometimes mediate depolarizations, with either inhibitory [237, 238] or excitatory [78, 239] effects on downstream synaptic activity.

In the process of presynaptic inhibition, GABA released at axo-axonic synapses activates GABAA receptors on the axon of the receiving neuron and prevents the propagation of synchronous action potentials [240] (Fig. 8). Unlike synaptic and perisynaptic inhibitions [241], presynaptic inhibition requires a precise synchronization of the excitatory signal with the chloride influx mediated by the GABAA receptor [198]. However, this does not necessarily imply that the GABA input must be synchronized with the action potentials: indeed, in certain retinal cells where ρ-containing subtypes are exclusively located in axons [213], the long-lasting signals mediated by these subtypes ensure an efficient presynaptic inhibition which allows a small delay between the inhibitory input and the action potentials.

Fig. 8.

Fig. 8

Presynaptic inhibition of action potentials mediated by GABAA receptors. Inhibitory currents mediated by GABAA receptors can inhibit simultaneous action potentials, and allow different axonal ramifications to convey different signals

The functions of presynaptic inhibition remain poorly understood [78]. However, the release of GABA by axons of hippocampal mossy fiber [242, 243] or cerebellar basket and stellar cells [244] suggests that one function of presynaptic inhibition is self-inhibition and tissular negative feedback on neuronal activity. In addition, presynaptic inhibition enables the axonal ramifications of a neuron to convey different messages if only part of the ramifications receive a presynaptic inhibitory signal (Fig. 8). This mechanism increases the complexity and specificity of neuronal communication [245]. For example, the presynaptic inhibition mediated by ρ-containing subtypes in the retina increases the dynamic range of brain responses to light intensity [246].

Control of GABAA receptor electrophysiology

GABAA receptor electrical activity is determined by GABA concentration and its intrinsic electrophysiological properties, but also by its chemical and cellular environment, sometimes in a subtype-specific manner.

GABAA receptor control by phosphorylation

GABAA receptors are subject to phosphorylation by several kinases such as protein kinase A (PKA) and C (PKC). Phosphorylation by PKC inhibits GABAA receptors, probably by endocytosis [247] or through an inhibition of the non-desensitizing fraction of GABAA receptors [248]. Both increases [249, 250] and decreases [147, 251253] in currents mediated by GABAA receptors have been reported upon phosphorylation by PKA, probably because it can simultaneously speed up desensitization while slowing down deactivation [254, 255]. In the retina, PKA mediates dopaminergic signals which result in a potentiation of GABAA receptors through a decrease in GABA EC50 [128]. Phosphorylation may explain the differences in electrophysiology between γ2S and γ2L containing receptors, since the only difference between these two splice forms is a cytoplasmic insertion of 8 residues in γ2L containing a PKC phosphorylation site [34].

Receptors of different neurotransmitters can colocalize at post-synaptic sites and be activated by presynaptic co-release of several neurotransmitters. The simultaneous activation of different postsynaptic receptors often induces a partial occlusion of their respective currents. This cross-talk has been proposed to represent a fast adaptive process in controlling signal transmission [256]. Negative cross-talk was demonstrated between GABAA receptors and dopamine receptors [256], P2X receptors [257] and glycine receptors [258]. The inhibition of GABAA receptors by glycine receptors depends on phosphatase 2B activity, while kinase activity is necessary for recovery of GABAA receptors from this inhibition [259].

Glutamate excitatory neurotransmission mediated by NMDA receptors induces calcineurin-dependent γ2 subunit dephosphorylation, leading to a reversible and local dispersion of postsynaptic GABAA receptor clusters [260]. Dispersion lowers receptors’ EC50, activation and desensitization times, and slows down their deactivation [261263]. Consequently, receptors transition from synaptic phasic activity to extrasynaptic tonic activity upon dephosphorylation.

Voltage dependency

Although GABAA receptors are generally voltage-independent, a few subtypes are voltage-sensitive in rare situations [123, 240, 264]. Voltage seems to affect current peak amplitude but not kinetic properties (desensitization and deactivation) of the α1β3δ, α5β3π and ρ1 subtypes [106, 123, 191, 192], unlike the α6β3δ subtype whose kinetic properties are affected but not other parameters [123]. Voltage dependency can also be observed in channels that are rare or never found in vivo, such as α1β3 or α6β3 [123].

Ionic modulation

GABAA receptors are sensitive to ionic modulation: a change in the concentration of certain ions, in either the extracellular or the cytosolic compartment, can modify their activity. The nature or extent of the modulation is subtype-specific (Fig. 9).

Fig. 9.

Fig. 9

Ionic modulation of the GABAA receptor. Ion flows are represented with black arrows, activation with green arrows and inhibition with red arrows. Dashed lines indicate subtype specificity

Extracellular Ca2+ does not affect the activity of ternary receptors [87, 265], but it increases the amplitude of currents mediated by ρ-containing subtypes [266]. Intracellular Ca2+ has varying effects on many subtypes, depending on its origin and concentration. Ca2+ coming from the extracellular space does not affect GABAA receptor opening [267], whereas Ca2+ originating from intracellular compartments activates GABAA receptors at low concentrations, but inhibits it at high concentrations [268, 269]. This may be a consequence of receptor phosphorylation by PKC [248] or dephosphorylation by calcineurin [260], because these enzymes are activated by intracellular calcium. Ca2+ control of GABAA receptors is involved in the long-run (seconds to minutes) modulation of neuronal activity [268].

Extracellular Zn2+ is released during synaptic activity by numerous neurons, particularly in the limbic and neocortical regions [270] and during development. It decreases the opening frequency of certain GABAA receptor subtypes [271] (reviewed in [4]). αβ receptors are up to 3400-fold more sensitive to Zn2+ than αβγ and αβδ receptors [113, 272], while ρ [266], αβπ [191] and αβε [126, 171] subtypes have an intermediate sensitivity. In addition, α1 confers a higher zinc sensitivity than the other α subunits [124, 126, 171, 182, 189, 273]. The discrepancy in sensitivity between αβγ and αβ subtypes is explained by the position of the Zn2+ binding sites in the receptor (two between α and β subunits and one in the ion pore), which are disturbed by γ subunits [182, 274]. Additionally, αβ subtypes comprised of two α and three β subunits contain a third zinc-binding site at the β-β interface, explaining their higher sensitivity compared with αβγ subtypes and the very rare αβ subtypes containing three α and two β subunits [129]. Zinc increases the EC50 of α1β1δ but not α1β1, and the Hill coefficient of α1β1 while it decreases the Hill coefficient of α1β1δ [273]. Zn2+ sensitivity displays very similar characteristics in vivo and in vitro (reviewed in [5]). Zn2+ may take part in the control of tonic currents in hippocampal pyramidal neurons, where up to 10% of extrasynaptic GABAA receptors may belong to αβ subtypes [180].

All GABAA receptor subtypes seem to be insensitive to intracellular pH [275] (reviewed in [4]), but certain subtypes are sensitive to extracellular pH because of their two extracellular proton-binding sites [170, 275]. Conductance is negatively correlated with extracellular pH for α1β1, α1β2γ2 and α1β1δ [170, 276], and positively for ρ subtypes [277, 278], while α1β1γ2S is pH-insensitive [170] and the curves of α1β1γ2Sδ, α4β3γ2, α4β3δ and α1β2γ2S conductance as a function of extracellular pH are bell-shaped [73, 170]. Extracellular protons slow the deactivation of the α1β3δ subtype and increase its opening probability in the absence of GABA without affecting its desensitization, resulting in an increase of currents at low pH [181]. On the contrary, α1β2γ2 desensitizes less and slower at low pH [276], while its activation is slowed, and deactivation is shifted toward its slow component. GABAA receptor inhibition at high pH is explained by a faster closure of the channel [279].

In vivo, GABAA channel charge transfer is generally negatively correlated with extracellular pH [170, 280]. During synaptic transmission, a transient acidosis of the synaptic cleft is followed by a durable increase in pH [281]. This phenomenon synergizes with the concomitant variations of GABA concentration and helps to induce a fast and massive opening of GABAA receptors during the first milliseconds of synaptic transmission, followed by the progressive closure of the channels when protons and GABA are cleared from the synaptic cleft.

NMDA, the glutamate receptor mediating most of the excitatory signals in the central nervous system, is inhibited by low pH [282]. Thus, the opposite effects of pH on the inhibitory GABAA receptor and the excitatory NMDA receptor may explain why neuronal activity and excitability increase with extracellular pH [283]. High regional electrical activity elicits an acidosis: the pH-sensitivity of GABAA receptor and NMDA receptor thus creates a negative feedback against hyperactivity. This process relies notably on tonic currents mediated by δ-containing receptors [181]. Other pH regulation processes can also modulate neurone activity through GABAA receptors [280]. Extracellular pH can itself be modified by bicarbonate transport across GABAA receptors [284], making them broadcasters of neuromodulatory signals in addition to their function of chloride channel.

Furthermore, acidity displays protective effects against Zn2+ inhibition in α1β1 receptors [273], showing that the different types of ionic modulation to which GABAA receptors are submitted are not independent.

The ionic modulation of the GABAA receptor is involved in the long-term depression or potentiation of inhibitory currents characteristic of neuronal plasticity, and may play a role in hypomagnesia-induced hyperexcitability [285], anoxic and ischaemic conditions [286] or epileptogenesis [287].

Conclusion

GABAA receptors are highly complex and are able to generate a vast repertoire of electric responses to different inputs under the control of various types of regulations. Their influence on cellular electric activity at different scales of time and space can to a great extent be predicted from the structural and electrophysiological properties of the different subtypes, whose diversity provides additional modularity, robustness and specialization to the GABAA receptor system.

GABAA receptor agonists and antagonists are increasingly used in medicine to treat various diseases, from epilepsy to insomnia and others. Improved knowledge of the electrophysiology, pharmacology and expression patterns of GABAA receptor subtypes has led to the development of subtype-specific drugs that limit side effects. Further studies on GABAA receptor electrophysiology are warranted in order to develop new treatments, particularly in the fields of GABAA receptors structure–function relationships, interactions with intracellular proteins, and electrical properties of lesser-known subtypes such as those containing π or θ subunits.

Acknowledgements

We are grateful to Thibault Pébrier1, Philibert Courau1 and María Castro Scherianz1 for their helpful review and comments of this article. 1 École Normale Supérieure de Paris, Biology department, PSL research university, 45 rue d’Ulm 75005 Paris, France

Author contributions

ES: conceptualization, data collection, curation and analysis, draft writing, manuscript review. DL: manuscript review. PL: supervision, manuscript review.

Funding

Open Access funding enabled and organized by Projekt DEAL.

Data availability

All data relevant to this review is included in the text, references and figs.

Code availability

Not applicable.

Declarations

Conflict of interest

None.

Ethics approval

Not applicable.

Consent to participate

Not applicable.

Consent for publication

Not applicable.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Bloom FE, Iversen LL. Localizing 3H-GABA in nerve terminals of rat cerebral cortex by electron microscopic autoradiography. Nature. 1971;229:628–630. doi: 10.1038/229628a0. [DOI] [PubMed] [Google Scholar]
  • 2.Young AB, Chu D. Distribution of GABAA and GABAB receptors in mammalian brain: potential targets for drug development. Drug Dev Res. 1990;21:161–167. doi: 10.1002/ddr.430210303. [DOI] [Google Scholar]
  • 3.Bormann J, Hamill OP, Sakmann B. Mechanism of anion permeation through channels gated by glycine and gamma-aminobutyric acid in mouse cultured spinal neurones. J Physiol. 1987;385:243–286. doi: 10.1113/jphysiol.1987.sp016493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Kaila K. Ionic basis of GABAA receptor channel function in the nervous system. Prog Neurobiol. 1994;42:489–537. doi: 10.1016/0301-0082(94)90049-3. [DOI] [PubMed] [Google Scholar]
  • 5.Zhang D, Pan Z-H, Awobuluyi M, Lipton SA. Structure and function of GABAC receptors: a comparison of native versus recombinant receptors. Trends Pharmacol Sci. 2001;22:121–132. doi: 10.1016/S0165-6147(00)01625-4. [DOI] [PubMed] [Google Scholar]
  • 6.Olsen RW, Sieghart W. International Union of Pharmacology. LXX. Subtypes of γ-aminobutyric acid a receptors: classification on the basis of subunit composition, pharmacology, and function. Update Pharmacol Rev. 2008;60:243–260. doi: 10.1124/pr.108.00505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Harvey RJ, Vreugdenhil E, Zaman SH, et al. Sequence of a functional invertebrate GABAA receptor subunit which can form a chimeric receptor with a vertebrate alpha subunit. EMBO J. 1991;10:3239–3245. doi: 10.1002/j.1460-2075.1991.tb04887.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Olsen RW, Tobin AJ. Molecular biology of GABAA receptors. FASEB J. 1990;4:1469–1480. doi: 10.1096/fasebj.4.5.2155149. [DOI] [PubMed] [Google Scholar]
  • 9.Sieghart W. Unraveling the function of GABAA receptor subtypes. Trends Pharmacol Sci. 2000;21:411–413. doi: 10.1016/S0165-6147(00)01564-9. [DOI] [PubMed] [Google Scholar]
  • 10.Olsen RW, Sieghart W. GABAA receptors: subtypes provide diversity of function and pharmacology. Neuropharmacology. 2009;56:141–148. doi: 10.1016/j.neuropharm.2008.07.045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Rabow LE, Russek SJ, Farb DH. From ion currents to genomic analysis: recent advances in GABAA receptor research. Synapse. 1995;21:189–274. doi: 10.1002/syn.890210302. [DOI] [PubMed] [Google Scholar]
  • 12.Sieghart W, Sperk G. Subunit composition, distribution and function of GABA-A receptor subtypes. CTMC. 2002;2:795–816. doi: 10.2174/1568026023393507. [DOI] [PubMed] [Google Scholar]
  • 13.Hevers W, Lüddens H. The diversity of GABAA receptors. Mol Neurobiol. 1998;18:35–86. doi: 10.1007/BF02741459. [DOI] [PubMed] [Google Scholar]
  • 14.Carter CR, Kozuska JL, Dunn SM. Insights into the structure and pharmacology of GABAA receptors. Future Med Chem. 2010;2:859–875. doi: 10.4155/fmc.10.178. [DOI] [PubMed] [Google Scholar]
  • 15.Chua HC, Chebib M. Advances in pharmacology. Elsevier; 2017. GABA A receptors and the diversity in their structure and pharmacology; pp. 1–34. [DOI] [PubMed] [Google Scholar]
  • 16.Hanrahan JR, Chebib M, Johnston GAR. Flavonoid modulation of GABAA receptors: flavonoids and GABAA receptors. Br J Pharmacol. 2011;163:234–245. doi: 10.1111/j.1476-5381.2011.01228.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.D’Hulst C, Atack JR, Kooy RF. The complexity of the GABAA receptor shapes unique pharmacological profiles. Drug Discov Today. 2009;14:866–875. doi: 10.1016/j.drudis.2009.06.009. [DOI] [PubMed] [Google Scholar]
  • 18.Johnston G. GABAA receptor channel pharmacology. CPD. 2005;11:1867–1885. doi: 10.2174/1381612054021024. [DOI] [PubMed] [Google Scholar]
  • 19.Johnston G. Medicinal chemistry and molecular pharmacology of GABA-C receptors. CTMC. 2002;2:903–913. doi: 10.2174/1568026023393453. [DOI] [PubMed] [Google Scholar]
  • 20.Möhler H. GABAA-receptor subtypes: a new pharmacology. Curr Opin Pharmacol. 2001;1:22–25. doi: 10.1016/S1471-4892(01)00008-X. [DOI] [PubMed] [Google Scholar]
  • 21.McCall MA, Lukasiewicz PD, Gregg RG, Peachey NS. Elimination of the rho1 subunit abolishes GABAC receptor expression and alters visual processing in the mouse retina. J Neurosci. 2002;22:4163–4174. doi: 10.1523/JNEUROSCI.22-10-04163.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Uusi-Oukari M, Korpi ER. Regulation of GABAA receptor subunit expression by pharmacological agents. Pharmacol Rev. 2010;62:97–135. doi: 10.1124/pr.109.002063. [DOI] [PubMed] [Google Scholar]
  • 23.Lévi S, Chesnoy-Marchais D, Sieghart W, Triller A. Synaptic control of glycine and GABAA receptors and gephyrin expression in cultured motoneurons. J Neurosci. 1999;19:7434–7449. doi: 10.1523/JNEUROSCI.19-17-07434.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Kittler JT, Moss SJ. Modulation of GABAA receptor activity by phosphorylation and receptor trafficking: implications for the efficacy of synaptic inhibition. Curr Opin Neurobiol. 2003;13:341–347. doi: 10.1016/S0959-4388(03)00064-3. [DOI] [PubMed] [Google Scholar]
  • 25.Lüscher B, Keller CA. Regulation of GABAA receptor trafficking, channel activity, and functional plasticity of inhibitory synapses. Pharmacol Ther. 2004;102:195–221. doi: 10.1016/j.pharmthera.2004.04.003. [DOI] [PubMed] [Google Scholar]
  • 26.v. Blankenfeld G, Kettenmann H. Glutamate and GABA receptors in vertebrate glial cells. Mol Neurobiol. 1991;5:31–43. doi: 10.1007/BF02935611. [DOI] [PubMed] [Google Scholar]
  • 27.Wang Q, Prud’homme G, Wan Y. GABAergic system in the endocrine pancreas: a new target for diabetes treatment. DMSO. 2015;8:79–87. doi: 10.2147/DMSO.S50642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Young SZ, Bordey A. GABA’s control of stem and cancer cell proliferation in adult neural and peripheral niches. Physiology. 2009;24:171–185. doi: 10.1152/physiol.00002.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Bjurstöm H, Wang J, Ericsson I, et al. GABA, a natural immunomodulator of T lymphocytes. J Neuroimmunol. 2008;205:44–50. doi: 10.1016/j.jneuroim.2008.08.017. [DOI] [PubMed] [Google Scholar]
  • 30.Egawa K, Fukuda A. Pathophysiological power of improper tonic GABAA conductances in mature and immature models. Front Neural Circuits. 2013 doi: 10.3389/fncir.2013.00170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Addolorato G, Leggio L, Hopf FW, et al. Novel therapeutic strategies for alcohol and drug addiction: focus on GABA, ion channels and transcranial magnetic stimulation. Neuropsychopharmacol. 2012;37:163–177. doi: 10.1038/npp.2011.216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Macdonald RL, Kang J-Q, Gallagher MJ. Mutations in GABAA receptor subunits associated with genetic epilepsies: GABAA receptor subunits associated with genetic epilepsies. J Physiol. 2010;588:1861–1869. doi: 10.1113/jphysiol.2010.186999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Bonnert TP, Mckernan RM, Farrar S, et al. theta, a novel gamma-aminobutyric acid type A receptor subunit. Proc Natl Acad Sci USA. 1999;96:9891–9896. doi: 10.1073/pnas.96.17.9891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Simon J, Wakimoto H, Fujita N, et al. Analysis of the set of GABAA receptor genes in the human genome. J Biol Chem. 2004;279:41422–41435. doi: 10.1074/jbc.M401354200. [DOI] [PubMed] [Google Scholar]
  • 35.Whiting P, Mckernan RM, Iversen LL. Another mechanism for creating diversity in gamma-aminobutyrate type A receptors: RNA splicing directs expression of two forms of gamma2 subunit, one of which contains a protein kinase C phosphorylation site. Proc Natl Acad Sci USA. 1990;87:9966–9970. doi: 10.1073/pnas.87.24.9966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Macdonald RL, Olsen RW. GABAA receptor channels. Annu Rev Neurosci. 1994;17:569–602. doi: 10.1146/annurev.ne.17.030194.003033. [DOI] [PubMed] [Google Scholar]
  • 37.Darlison MG. Invertebrate GABA and glutamate receptors: molecular biology reveals predictable structures but some unusual pharmacologies. Trends Neurosci. 1992;15:469–474. doi: 10.1016/0166-2236(92)90091-L. [DOI] [PubMed] [Google Scholar]
  • 38.Jones A, Korpi ER, McKernan RM, et al. Ligand-gated ion channel subunit partnerships: GABAA receptor alpha6 subunit gene inactivation inhibits delta subunit expression. J Neurosci. 1997;17:1350–1362. doi: 10.1523/JNEUROSCI.17-04-01350.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Mihalek RM, Banerjee PK, Korpi ER, et al. Attenuated sensitivity to neuroactive steroids in gamma-aminobutyrate type A receptor delta subunit knockout mice. Proc Natl Acad Sci USA. 1999;96:12905–12910. doi: 10.1073/pnas.96.22.12905. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Sur C, Wafford KA, Reynolds DS, et al. Loss of the Major GABAA receptor subtype in the brain is not lethal in mice. J Neurosci. 2001;21:3409–3418. doi: 10.1523/JNEUROSCI.21-10-03409.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Vollenweider I, Smith KS, Keist R, Rudolph U. Antidepressant-like properties of α2-containing GABAA receptors. Behav Brain Res. 2011;217:77–80. doi: 10.1016/j.bbr.2010.10.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Culiat CT, Rinchik EM. Phenotypic consequences of deletion of the gamma3, alpha5, or beta3 subunit of the type A gamma-aminobutyric acid receptor in mice. Proc Natl Acad Sci USA. 1994;91:2815–2818. doi: 10.1073/pnas.91.7.2815. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Amundarain MJ, Ribeiro RP, Costabel MD, Giorgetti A. GABAA receptor family: overview on structural characterization. Future Med Chem. 2019;11:229–245. doi: 10.4155/fmc-2018-0336. [DOI] [PubMed] [Google Scholar]
  • 44.Scott S, Aricescu AR. A structural perspective on GABAA receptor pharmacology. Curr Opin Struct Biol. 2019;54:189–197. doi: 10.1016/j.sbi.2019.03.023. [DOI] [PubMed] [Google Scholar]
  • 45.Masiulis S, Desai R, Uchański T, et al. GABAA receptor signalling mechanisms revealed by structural pharmacology. Nature. 2019;565:454–459. doi: 10.1038/s41586-018-0832-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Rossokhin AV. Homology modeling of the transmembrane domain of the GABAA receptor. Biophysics. 2017;62:708–716. doi: 10.1134/S0006350917050190. [DOI] [Google Scholar]
  • 47.Chang Y, Weiss DS. Allosteric activation mechanism of the alpha1beta2gamma2 gamma-aminobutyric acid type A receptor revealed by mutation of the conserved M2 leucine. Biophys J. 1999;77:2542–2551. doi: 10.1016/S0006-3495(99)77089-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Jechlinger M, Pelz R, Tretter V, et al. Subunit composition and quantitative importance of hetero-oligomeric receptors: GABAA receptors containing alpha6 subunits. J Neurosci. 1998;18:2449–2457. doi: 10.1523/JNEUROSCI.18-07-02449.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Mertens S, Benke D, MohlerS H. GABAA receptor populations with novel subunit combinations and drug binding profiles identified in brain by alpha5- and delta subunit-specific immunopurification. J Biol Chem. 1993;268:5965–5973. doi: 10.1016/S0021-9258(18)53413-X. [DOI] [PubMed] [Google Scholar]
  • 50.Lüddens H, Killisch I, Seeburg PH. More than one alpha variant may exist in a GabaA/benzodiazepine receptor complex. J Recept Res. 1991;11:535–551. doi: 10.3109/10799899109066426. [DOI] [PubMed] [Google Scholar]
  • 51.Li M, Blas ALD. Coexistence of two beta subunit isoforms in the same gamma-aminobutyric acid type A receptor. J Biol Chem. 1997;272:16564–16569. doi: 10.1074/jbc.272.26.16564. [DOI] [PubMed] [Google Scholar]
  • 52.Duggan MJ, Pollard S, Stephenson FA. Immunoaffinity purification of GABAA receptor alpha-subunit iso-oligomers. Demonstration of receptor populations containing alpha 1 alpha 2, alpha 1 alpha 3, and alpha 2 alpha 3 subunit pairs. J Biol Chem. 1991;266:24778–24784. doi: 10.1016/S0021-9258(18)54297-6. [DOI] [PubMed] [Google Scholar]
  • 53.Zezula J, Sieghart W. Isolation of type I and type II GABAA-benzodiazepine receptors by immunoaffinity chromatography. FEBS Lett. 1991;284:15–18. doi: 10.1016/0014-5793(91)80750-W. [DOI] [PubMed] [Google Scholar]
  • 54.Bormann J. The ‘ABC’ of GABA receptors. Trends Pharmacol Sci. 2000;21:16–19. doi: 10.1016/S0165-6147(99)01413-3. [DOI] [PubMed] [Google Scholar]
  • 55.Backus K, Arigoni M, Drescher U, et al. Stoichiometry of a recombinant GABAA receptor deduced from mutation-induced rectification. NeuroReport. 1993;5:285–288. doi: 10.1097/00001756-199312000-00026. [DOI] [PubMed] [Google Scholar]
  • 56.Brickley SG, Cull-Candy SG, Farrant M. Single-channel properties of synaptic and extrasynaptic GABAA receptors suggest differential targeting of receptor subtypes. J Neurosci. 1999;19:2960–2973. doi: 10.1523/JNEUROSCI.19-08-02960.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Gunther U, Benson J, Benke D, et al. Benzodiazepine-insensitive mice generated by targeted disruption of the y2 subunit gene of y-aminobutyric acid type A receptors. Proc Natl Acad Sci USA. 1995;92:7749–7753. doi: 10.1073/pnas.92.17.7749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Tretter V, Hauer B, Nusser Z, et al. Targeted disruption of the GABAA receptor δ subunit gene leads to an up-regulation of γ2 subunit-containing receptors in cerebellar granule cells. J Biol Chem. 2001;276:10532–10538. doi: 10.1074/jbc.M011054200. [DOI] [PubMed] [Google Scholar]
  • 59.Enz R, Cutting GR. Molecular composition of GABAC receptors. Vis Res. 1998;38:1431–1441. doi: 10.1016/S0042-6989(97)00277-0. [DOI] [PubMed] [Google Scholar]
  • 60.Cutting GR, Donovan DM, Shimada S, et al. Cloning of the y-aminobutyric acid (GABA) P1 cDNA: a GABA receptor subunit highly expressed in the retina. Proc Natl Acad Sci USA. 1991;88:2673–2677. doi: 10.1073/pnas.88.7.2673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Milligan CJ. Evidence for inhibition mediated by coassembly of GABAA and GABAC receptor subunits in native central neurons. J Neurosci. 2004;24:7241–7250. doi: 10.1523/JNEUROSCI.1979-04.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Harvey VL, Duguid IC, Krasel C, Stephens GJ. Evidence that GABA ρ subunits contribute to functional ionotropic GABA receptors in mouse cerebellar Purkinje cells: ionotropic GABA receptors in Purkinje cells. J Physiol. 2006;577:127–139. doi: 10.1113/jphysiol.2006.112482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Tyndale F, Hales G. Distinctive patterns of GABA, receptor subunit mRNAs in 13 cell lines. J Neurosci. 1994;14:5417–5428. doi: 10.1523/JNEUROSCI.14-09-05417.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Laurie DJ, Seeburg PH, Wisden W. The distribution of 13 GABA, receptor subunit mRNAs in the rat brain. II. Olfactory bulb and cerebellum. J Neurosci. 1992;12:1063–1076. doi: 10.1523/JNEUROSCI.12-03-01063.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Rudolph U, Knoflach F. Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes. Nat Rev Drug Discov. 2011;10:685–697. doi: 10.1038/nrd3502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Whiting PJ. GABA-A receptor subtypes in the brain: a paradigm for CNS drug discovery? Drug Discov Today. 2003;8:445–450. doi: 10.1016/S1359-6446(03)02703-X. [DOI] [PubMed] [Google Scholar]
  • 67.Thompson SM, Deisz RA, Prince DA. Outward chloride/cation co-transport in mammalian cortical neurons. Neurosci Lett. 1988;89:49–54. doi: 10.1016/0304-3940(88)90479-X. [DOI] [PubMed] [Google Scholar]
  • 68.Kaila K, Voipio J, Paalasmaa P, et al. The role of bicarbonate in GABAA receptor-mediated IPSPs of rat neocortical neurones. J Physiol. 1993;464:273–289. doi: 10.1113/jphysiol.1993.sp019634. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Chen G, Trombley PQ, van den Pol AN. Excitatory actions of GABA in developing rat hypothalamic neurones. J Physiol. 1996;494:451–464. doi: 10.1113/jphysiol.1996.sp021505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Rivera C, Voipio J, Payne JA, et al. The K+/Cl− co-transporter KCC2 renders GABA hyperpolarizing during neuronal maturation. Nature. 1999;397:251–255. doi: 10.1038/16697. [DOI] [PubMed] [Google Scholar]
  • 71.Serafini R, Valeyev AY, Barker JL, Poulter MO. Depolarizing GABA-activated Cl− channels in embryonic rat spinal and olfactory bulb cells. J Physiol. 1995;488:371–386. doi: 10.1113/jphysiol.1995.sp020973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Cherubini E, Gaiarsa JL, Ben-Aft Y. GABA: an excitatory transmitter in early postnatal life. TINS. 1991;14:515–519. doi: 10.1016/0166-2236(91)90003-d. [DOI] [PubMed] [Google Scholar]
  • 73.Brickley SG, Cull-Candy SG, Farrant M. Development of a tonic form of synaptic inhibition in rat cerebellar granule cells resulting from persistent activation of GABAA receptors. J Physiol. 1996;497:753–759. doi: 10.1113/jphysiol.1996.sp021806. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Michelson H, Wong R. Excitatory synaptic responses mediated by GABAA receptors in the hippocampus. Science. 1991;253:1420–1423. doi: 10.1126/science.1654594. [DOI] [PubMed] [Google Scholar]
  • 75.Glykys J, Staley KJ. Developmental decrease of neuronal chloride concentration is independent of trauma in thalamocortical brain slices. PLoS ONE. 2016;11:e0158012. doi: 10.1371/journal.pone.0158012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Staley KJ, Mody I. Shunting of excitatory input to dentate gyrus granule cells by a depolarizing GABAA receptor-mediated postsynaptic conductance. J Neurophysiol. 1992;68:197–212. doi: 10.1152/jn.1992.68.1.197. [DOI] [PubMed] [Google Scholar]
  • 77.Graham B, Redman S. A simulation of action potentials in synaptic boutons during presynaptic inhibition. J Neurophysiol. 1994;71:538–549. doi: 10.1152/jn.1994.71.2.538. [DOI] [PubMed] [Google Scholar]
  • 78.Kullmann DM, Ruiz A, Rusakov DM, et al. Presynaptic, extrasynaptic and axonal GABAA receptors in the CNS: where and why? Prog Biophys Mol Biol. 2005;87:33–46. doi: 10.1016/j.pbiomolbio.2004.06.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Verdier D, Lund JP, Kolta A. GABAergic control of action potential propagation along axonal branches of mammalian sensory neurons. J Neurosci. 2003;23:2002–2007. doi: 10.1523/JNEUROSCI.23-06-02002.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Chavas J, Forero ME, Collin T, et al. Osmotic tension as a possible link between GABAA receptor activation and intracellular calcium elevation. Neuron. 2004;44:701–713. doi: 10.1016/j.neuron.2004.11.002. [DOI] [PubMed] [Google Scholar]
  • 81.Llinás R, Mühlethaler M. Electrophysiology of guinea-pig cerebellar nuclear cells in the in vitro brain stem-cerebellar preparation. J Physiol. 1988;404:241–258. doi: 10.1113/jphysiol.1988.sp017288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Owens DF, Kriegstein AR. Is there more to GABA than synaptic inhibition? Nat Rev Neurosci. 2002;3:715–727. doi: 10.1038/nrn919. [DOI] [PubMed] [Google Scholar]
  • 83.Barbin G, Pollard H, Gaïarsa JL, Ben-Ari Y. Involvement of GABAA receptors in the outgrowth of cultured hippocampal neurons. Neurosci Lett. 1993;152:150–154. doi: 10.1016/0304-3940(93)90505-F. [DOI] [PubMed] [Google Scholar]
  • 84.Meier J, Akyeli J, Kirischuk S, Grantyn R. GABAA receptor activity and PKC control inhibitory synaptogenesis in CNS tissue slices. Mol Cell Neurosci. 2003;23:600–613. doi: 10.1016/S1044-7431(03)00079-4. [DOI] [PubMed] [Google Scholar]
  • 85.Behar T, Schaffner A, Colton C, et al. GABA-induced chemokinesis and NGF-induced chemotaxis of embryonic spinal cord neurons. J Neurosci. 1994;14:29–38. doi: 10.1523/JNEUROSCI.14-01-00029.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Mount TJ, Dreyfus F, Black IB. Purkinje cell survival is differentially regulated by metabotropic and lonotropic excitatory amino acid receptors. J Neurosci. 1993;13:3173–3179. doi: 10.1523/JNEUROSCI.13-07-03173.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Takeuchi A, Takeuchi N. Anion interaction at the inhibitory post-synaptic membrane of the crayfish neuromuscular junction. J Physiol. 1971;212:337–351. doi: 10.1113/jphysiol.1971.sp009328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Voipio J, Kaila K. Progress in brain research. Elsevier; 2000. GABAergic excitation and K+-mediated volume transmission in the hippocampus; pp. 329–338. [DOI] [PubMed] [Google Scholar]
  • 89.Barker JL, Ransom BR. Amino acid pharmacology of mammalian central neurones grown in tissue culture. J Physiol. 1978;280:331–354. doi: 10.1113/jphysiol.1978.sp012387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Kim D-Y, Fenoglio K, Kerrigan J, Rho J. Bicarbonate contributes to GABAA receptor-mediated neuronal excitation in surgically resected human hypothalamic hamartomas. Epilepsy Res. 2009;83:89–93. doi: 10.1016/j.epilpesyres.2008.09.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Staley KJ, Proctor WR. Modulation of mammalian dendritic GABAA receptor function by the kinetics of Cl− and HCO3− transport. J Physiol. 1999;519:693–712. doi: 10.1111/j.1469-7793.1999.0693n.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Staley K, Soldo B, Proctor W. Ionic mechanisms of neuronal excitation by inhibitory GABAA receptors. Science. 1995;269:977–981. doi: 10.1126/science.7638623. [DOI] [PubMed] [Google Scholar]
  • 93.Bianchi MT, Song L, Zhang H, Macdonald RL. Two different mechanisms of disinhibition produced by GABAA receptor mutations linked to epilepsy in humans. J Neurosci. 2002;22:5321–5327. doi: 10.1523/JNEUROSCI.22-13-05321.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94.Huntsman MM, Porcello DM, Homanics GE, et al. Reciprocal inhibitory connections regulate the spatiotemporal properties of intrathalamic oscillations. J Neurosci. 2000;20:1735–1745. doi: 10.1523/JNEUROSCI.20-05-01735.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Whittington MA, Traub RD, Jefferys JGR. Synchronized oscillations in interneuron networks driven by metabotropic glutamate receptor activation. Nature. 1995;373:612–615. doi: 10.1038/373612a0. [DOI] [PubMed] [Google Scholar]
  • 96.Steinbach JH, Akk G. Applying the Monod–Wyman–Changeux allosteric activation model to pseudo-steady-state responses from GABAA receptors. Mol Pharmacol. 2019;95:106–119. doi: 10.1124/mol.118.113787. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Akk G, Shin DJ, Germann AL, Steinbach JH. GABA type A receptor activation in the allosteric coagonist model framework: relationship between EC50 and basal activity. Mol Pharmacol. 2018;93:90–100. doi: 10.1124/mol.117.110569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98.Ruesch D, Neumann E, Wulf H, Forman SA. An allosteric coagonist model for propofol effects on α1β2γ2L γ-aminobutyric acid type A receptors. Anesthesiology. 2012;116:47–55. doi: 10.1097/ALN.0b013e31823d0c36. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99.Gielen MC, Lumb MJ, Smart TG. Benzodiazepines modulate GABAA receptors by regulating the preactivation step after GABA binding. J Neurosci. 2012;32:5707–5715. doi: 10.1523/JNEUROSCI.5663-11.2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Lavoie AM, Tingey JJ, Harrison NL, et al. Activation and deactivation rates of recombinant GABA(A) receptor channels are dependent on alpha-subunit isoform. Biophys J. 1997;73:2518–2526. doi: 10.1016/S0006-3495(97)78280-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101.Bianchi MT, Macdonald RL. Slow phases of GABAA receptor desensitization: structural determinants and possible relevance for synaptic function. J Physiol. 2002;544:3–18. doi: 10.1113/jphysiol.2002.020255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102.Jones MV, Westbrook GL. Desensitized states prolong GABAA channel responses to brief agonist pulses. Neuron. 1995;15:181–191. doi: 10.1016/0896-6273(95)90075-6. [DOI] [PubMed] [Google Scholar]
  • 103.McClellan AML, Twyman RE. Receptor system response kinetics reveal functional subtypes of native murine and recombinant human GABAA receptors. J Physiol. 1999;515:711–727. doi: 10.1111/j.1469-7793.1999.711ab.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 104.Twyman RE, Macdonald RL. Neurosteroid regulation of GABAA receptor single-channel kinetic properties of mouse spinal cord neurons in culture. J Physiol. 1992;456:215–245. doi: 10.1113/jphysiol.1992.sp019334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 105.Maconochie DJ, Zempel JM, Steinbach JH. How quickly can GABAA receptors open? Neuron. 1994;12:61–71. doi: 10.1016/0896-6273(94)90152-X. [DOI] [PubMed] [Google Scholar]
  • 106.Chang Y, Weiss DS. Channel opening locks agonist onto the GABAC receptor. Nat Neurosci. 1999;2:219–225. doi: 10.1038/6313. [DOI] [PubMed] [Google Scholar]
  • 107.Lindquist CEL, Birnir B. Graded response to GABA by native extrasynaptic GABAA receptors. J Neurochem. 2006;97:1349–1356. doi: 10.1111/j.1471-4159.2006.03811.x. [DOI] [PubMed] [Google Scholar]
  • 108.Korpi ER, Mihalek RM, Sinkkonen ST, et al. Altered receptor subtypes in the forebrain of GABAA receptor δ subunit-deficient mice: recruitment of γ2 subunits. Neuroscience. 2002;109:733–743. doi: 10.1016/S0306-4522(01)00527-9. [DOI] [PubMed] [Google Scholar]
  • 109.Feng H, Jounaidi Y, Haburcak M, et al. Etomidate produces similar allosteric modulation in α1β3δ and α1β3γ2 L GABAA receptors. Br J Pharmacol. 2014;171:789–798. doi: 10.1111/bph.12507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 110.Gingrich KJ, Roberts WA, Kass RS. Dependence of the GABAA receptor gating kinetics on the alpha-subunit isoform: implications for structure–function relations and synaptic transmission. J Physiol. 1995;489:529–543. doi: 10.1113/jphysiol.1995.sp021070. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 111.Picton AJ, Fisher JL. Effect of the α subunit subtype on the macroscopic kinetic properties of recombinant GABAA receptors. Brain Res. 2007;1165:40–49. doi: 10.1016/j.brainres.2007.06.050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 112.Lagrange AH, Botzolakis EJ, Macdonald RL. Enhanced macroscopic desensitization shapes the response of α4 subtype-containing GABAA receptors to synaptic and extrasynaptic GABA: enhanced fast desensitization in α4 subunit-containing GABAA receptors. J Physiol. 2007;578:655–676. doi: 10.1113/jphysiol.2006.122135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 113.Brown N, Kerby J, Bonnert TP, et al. Pharmacological characterization of a novel cell line expressing human α4β3δ GABAA receptors. Br J Pharmacol. 2002;136:965–974. doi: 10.1038/sj.bjp.0704795. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 114.Haas KF, Macdonald RL. GABAA receptor subunit γ2 and δ subtypes confer unique kinetic properties on recombinant GABAA receptor currents in mouse fibroblasts. J Physiol. 1999;514:27–45. doi: 10.1111/j.1469-7793.1999.027af.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 115.Olander ER, Janzen D, Villmann C, Jensen A. Comparison of biophysical properties of a1b2 and a3b2 GABAA receptors in whole-cell patch-clamp electrophysiological recordings. PLoS ONE. 2020;15:e0234080. doi: 10.1371/journal.pone.0234080. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 116.Enz R, Cutting GR. GABAC receptor ρ subunits are heterogeneously expressed in the human CNS and form homo- and heterooligomers with distinct physical properties: analysis of individually and coexpressed ρ subunits. Eur J Neurosci. 1999;11:41–50. doi: 10.1046/j.1460-9568.1999.00423.x. [DOI] [PubMed] [Google Scholar]
  • 117.Belujon P, Baufreton J, Grandoso L, et al. Inhibitory transmission in locus coeruleus neurons expressing GABAA receptor epsilon subunit has a number of unique properties. J Neurophysiol. 2009;102:2312–2325. doi: 10.1152/jn.00227.2009. [DOI] [PubMed] [Google Scholar]
  • 118.Mazzuferi M, Palma E, Martinello K, et al. Enhancement of GABAA-current run-down in the hippocampus occurs at the first spontaneous seizure in a model of temporal lobe epilepsy. Proc Natl Acad Sci. 2010;107:3180–3185. doi: 10.1073/pnas.0914710107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 119.Tureček R, Trussell LO. Control of synaptic depression by glutamate transporters. J Neurosci. 2000;20:2054–2063. doi: 10.1523/JNEUROSCI.20-05-02054.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 120.Gielen M, Barilone N, Corringer P-J. The desensitization pathway of GABAA receptors, one subunit at a time. Nat Commun. 2020;11:5369. doi: 10.1038/s41467-020-19218-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 121.Ortinski PI, Lu C, Takagaki K, et al. Expression of distinct α subunits of GABAA receptor regulates inhibitory synaptic strength. J Neurophysiol. 2004;92:1718–1727. doi: 10.1152/jn.00243.2004. [DOI] [PubMed] [Google Scholar]
  • 122.Fisher JL. A mutation in the GABAA receptor α1 subunit linked to human epilepsy affects channel gating properties. Neuropharmacology. 2004;46:629–637. doi: 10.1016/j.neuropharm.2003.11.015. [DOI] [PubMed] [Google Scholar]
  • 123.Bianchi MT, Haas KF, Macdonald RL. α1 and α6 subunits specify distinct desensitization, deactivation and neurosteroid modulation of GABAA receptors containing the δ subunit. Neuropharmacology. 2002;43:492–502. doi: 10.1016/S0028-3908(02)00163-6. [DOI] [PubMed] [Google Scholar]
  • 124.Burgard C, Tietz I, Neelands R, Macdonald L. Properties of recombinant gamma-aminobutyric acidA receptor isoforms containing the alpha5 subunit subtype. Mol Pharmacol. 1996;50:119–127. [PubMed] [Google Scholar]
  • 125.Saxenal NC, Macdonald L. Assembly of GABA, receptor subunits: role of the delta subunit. J Neurosci. 1994;14:7077–7086. doi: 10.1523/JNEUROSCI.14-11-07077.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 126.Whiting PJ, McAllister G, Vassilatis D, et al. Neuronally restricted RNA splicing regulates the expression of a novel GABAA receptor subunit conferring atypical functional properties. J Neurosci. 1997;17:5027–5037. doi: 10.1523/JNEUROSCI.17-13-05027.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 127.Qian H, Dowling JE. Novel GABA responses from rod-driven retinal horizontal cells. Nature. 1993;361:162–164. doi: 10.1038/361162a0. [DOI] [PubMed] [Google Scholar]
  • 128.Feigenspan A, Bormann J. GABA-gated CI-channels in the rat retina. Prog Retin Eye Res. 1998;17:99–126. doi: 10.1016/S1350-9462(97)00008-6. [DOI] [PubMed] [Google Scholar]
  • 129.Che Has A, Absalom N, van Nieuwenhuijzen P, et al. Zolpidem is a potent stoichiometry-selective modulator of a1b3 GABAA receptors: evidence of a novel benzodiazepine site in the a1–a1 interface. Sci Rep. 2016;6:28674. doi: 10.1038/srep28674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 130.Fisher JL, Macdonald RL. Single channel properties of recombinant GABA A receptors containing γ2 or δ subtypes expressed with α1 and β3 subtypes in mouse L929 cells. J Physiol. 1997;505:283–297. doi: 10.1111/j.1469-7793.1997.283bb.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 131.Overstreet LS, Jones MV, Westbrook GL. Slow desensitization regulates the availability of synaptic GABAA receptors. J Neurosci. 2000;20:7914–7921. doi: 10.1523/JNEUROSCI.20-21-07914.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 132.Germann AL, Pierce SR, Senneff TC, et al. Steady-state activation and modulation of the synaptic-type α1β2γ2L GABAA receptor by combinations of physiological and clinical ligands. Physiol Rep. 2019;7:e14230. doi: 10.14814/phy2.14230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 133.Burgard EC, Haas KF, Macdonald RL. Channel properties determine the transient activation kinetics of recombinant GABAA receptors. Mol Brain Res. 1999;73:28–36. doi: 10.1016/S0169-328X(99)00230-2. [DOI] [PubMed] [Google Scholar]
  • 134.Overstreet LS, Westbrook GL. Transmembrane transporters. 1. New York: Wiley; 2002. Measuring and modeling the spatiotemporal profile of GABA at the synapse; pp. 259–275. [Google Scholar]
  • 135.Bianchi MT, Macdonald RL. Agonist Trapping by GABAA receptor channels. J Neurosci. 2001;21:9083–9091. doi: 10.1523/JNEUROSCI.21-23-09083.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 136.Baker PM, Pennefather PS, Orser BA, Skinner FK. Disruption of coherent oscillations in inhibitory networks with anesthetics: role of GABAA receptor desensitization. J Neurophysiol. 2002;88:2821–2833. doi: 10.1152/jn.00052.2002. [DOI] [PubMed] [Google Scholar]
  • 137.Kaneda M, Farrant M, Cull-Candy SG. Whole-cell and single-channel currents activated by GABA and glycine in granule cells of the rat cerebellum. J Physiol. 1995;485:419–435. doi: 10.1113/jphysiol.1995.sp020739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 138.Boileau AJ, Li T, Benkwitz C, et al. Effects of γ2S subunit incorporation on GABAA receptor macroscopic kinetics. Neuropharmacology. 2003;44:1003–1012. doi: 10.1016/S0028-3908(03)00114-X. [DOI] [PubMed] [Google Scholar]
  • 139.Benkwitz C. Influence of GABAA receptor gamma2 splice variants on receptor kinetics and isoflurane modulation. Anesthesiology. 2004;101:924–936. doi: 10.1097/00000542-200410000-00018. [DOI] [PubMed] [Google Scholar]
  • 140.Lagrange A, Macdonald R. Enhanced desensitization in alpha4 containing GABAA receptors. Epilepsia. 2005;46:113. [Google Scholar]
  • 141.Macdonald RL, Rogers CJ, Twyman RE. Kinetic properties of the GABAA receptor main conductance state of mouse spinal cord neurones in culture. J Physiol. 1989;410:479–499. doi: 10.1113/jphysiol.1989.sp017545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 142.Twyman RE, Rogers CJ, Macdonald RL. Intraburst kinetic properties of the GABAA receptor main conductance state of mouse spinal cord neurones in culture. J Physiol. 1990;423:193–220. doi: 10.1113/jphysiol.1990.sp018018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 143.Colquhoun D, Hawkes AG. The principles of the stochastic interpretation of ion-channel mechanisms. In: Sakmann B, Neher E, editors. Single-channel recording. Boston: Springer US; 1995. pp. 397–482. [Google Scholar]
  • 144.Chang Y, Ghansah E, Chen Y, et al. Desensitization mechanism of GABA receptors revealed by single oocyte binding and receptor function. J Neurosci. 2002;22:7982–7990. doi: 10.1523/JNEUROSCI.22-18-07982.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 145.Angelotti TP, Macdonald RL. Assembly of GABA, receptor subunits: alpha1beta1 and alpha1beta1gamma2S subunits produce unique ion channels with dissimilar single-channel properties. J Neurosci. 1993;13:1429–1440. doi: 10.1523/JNEUROSCI.13-04-01429.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 146.Angelotti TP, Uhler D, McDonald BJ. Assembly of GABA, receptor subunits: analysis of transient single-cell expression utilizing a fluorescent substrate/marker gene technique. J Neurosci. 1993;13:1418–1428. doi: 10.1523/JNEUROSCI.13-04-01418.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 147.Feigenspan A, Bormann J. Differential pharmacology of GABAA and GABAC receptors on rat retinal bipolar cells. Eur J Pharmacol Mol Pharmacol. 1994;288:97–104. doi: 10.1016/0922-4106(94)90014-0. [DOI] [PubMed] [Google Scholar]
  • 148.Feigenspan A, Wässle H, Bormann J. Pharmacology of GABA receptor CI—channels in rat retinal bipolar cells. Nature. 1993;361:159–162. doi: 10.1038/361159a0. [DOI] [PubMed] [Google Scholar]
  • 149.Sigworth FJ. The variance of sodium current fluctuations at the node of Ranvier. J Physiol. 1980;307:97–129. doi: 10.1113/jphysiol.1980.sp013426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 150.Olsen RW. Drug interactions at the GABA receptor–ionophore complex. Annu Rev Pharmacol Toxicol. 1982;22:245–277. doi: 10.1146/annurev.pa.22.040182.001333. [DOI] [PubMed] [Google Scholar]
  • 151.Böhme I, Rabe H, Lüddens H. Four amino acids in the α subunits determine the γ-aminobutyric acid sensitivities of GABAA receptor subtypes. J Biol Chem. 2004;279:35193–35200. doi: 10.1074/jbc.M405653200. [DOI] [PubMed] [Google Scholar]
  • 152.Verdoorn A. Functional properties of recombinant rat GABAA receptors depend upon subunit composition. Neuron. 1990;4:919–928. doi: 10.1016/0896-6273(90)90145-6. [DOI] [PubMed] [Google Scholar]
  • 153.Sigel E, Baur R. Electrophysiological evidence for the coexistence of α1 and α6 subunits in a single functional GABAA receptor. J Neurochem. 2002;74:2590–2596. doi: 10.1046/j.1471-4159.2000.0742590.x. [DOI] [PubMed] [Google Scholar]
  • 154.Sigel E, Baur R, Trube G, et al. The effect of subunit composition of rat brain GABAA receptors on channel function. Neuron. 1990;5:703–711. doi: 10.1016/0896-6273(90)90224-4. [DOI] [PubMed] [Google Scholar]
  • 155.Hansen SL, Ebert B, Fjalland B, Kristiansen U. Effects of GABAA receptor partial agonists in primary cultures of cerebellar granule neurons and cerebral cortical neurons reflect different receptor subunit compositions. Br J Pharmacol. 2001;133:539–549. doi: 10.1038/sj.bjp.0704121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 156.Hevers W, Korpi ER, Lüddens H. Assembly of functional α6β3γ2δ GABAA receptors in vitro. NeuroReport. 2000;11:4103–4106. doi: 10.1097/00001756-200012180-00038. [DOI] [PubMed] [Google Scholar]
  • 157.Fisher JL, Macdonald RL. Functional properties of recombinant GABAA receptors composed of single or multiple β subunit subtypes. Neuropharmacology. 1997;36:1601–1610. doi: 10.1016/S0028-3908(97)00133-0. [DOI] [PubMed] [Google Scholar]
  • 158.Dostalova Z, Zhou X, Liu A, et al. Human α1β3γ2L gamma-aminobutyric acid type A receptors: high-level production and purification in a functional state: purification of functional α1β3γ2 GABAA receptors. Protein Sci. 2014;23:157–166. doi: 10.1002/pro.2401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 159.Legendre P, Muller E, Badiu CI, et al. Desensitization of homomeric α1 glycine receptor increases with receptor density. Mol Pharmacol. 2002;62:817–827. doi: 10.1124/mol.62.4.817. [DOI] [PubMed] [Google Scholar]
  • 160.Davies PA, Kirkness EF, Hales TG. Modulation by general anaesthetics of rat GABAA receptors comprised of α1β3 and β3 subunits expressed in human embryonic kidney 293 cells. Br J Pharmacol. 1997;120:899–909. doi: 10.1038/sj.bjp.0700987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 161.Neelands TR, Fisher JL, Bianchi M, Macdonald RL. Spontaneous and gamma-aminobutyric acid (GABA)-activated GABAA receptor channels formed by epsilon subunit-containing isoforms. Mol Pharmacol. 1999;1:168–178. doi: 10.1124/mol.55.1.168. [DOI] [PubMed] [Google Scholar]
  • 162.López-Chávez A, Miledi R, Martínez-Torres A. Cloning and functional expression of the bovine GABAC ρ2 subunit. Neurosci Res. 2005;53:421–427. doi: 10.1016/j.neures.2005.08.014. [DOI] [PubMed] [Google Scholar]
  • 163.Ebert B, Wafford KA, Whiting PJ, et al. Molecular pharmacology of gamma-aminobutyric acid type A receptor agonists and partial agonists in oocytes injected with different alpha, beta, and gamma receptor subunit combinations. Mol Pharmacol. 1994;46:957–963. [PubMed] [Google Scholar]
  • 164.Wafford KA, Bain CJ, Whiting PJ, Kemp JA. Functional comparison of the role of gamma subunits in recombinant human gamma-aminobutyric acidA/benzodiazepine receptors. Mol Pharmacol. 1993;44:437–442. [PubMed] [Google Scholar]
  • 165.Horne AL, Harkness PC, Hadingham KL, et al. The influence of the γ2L subunit on the modulation of responses to GABAA receptor activation. Br J Pharmacol. 1993;108:711–716. doi: 10.1111/j.1476-5381.1993.tb12866.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 166.Malherbe P, Draguhn A, Multhaup G. GABAA-receptor expressed from rat brain a- and fl-subunit cDNAs displays potentiation by benzodiazepine receptor ligands. Mol Brain Res. 1990;8:199–208. doi: 10.1016/0169-328X(90)90017-8. [DOI] [PubMed] [Google Scholar]
  • 167.Ducić I, Caruncho HJ, Zhu WJ, et al. gamma-Aminobutyric acid gating of Cl- channels in recombinant GABAA receptors. J Pharmacol Exp Ther. 1995;272:438–445. [PubMed] [Google Scholar]
  • 168.Hadingham KL, Harkness PC, McKernan RM, et al. Stable expression of mammalian type A gamma-aminobutyric acid receptors in mouse cells: demonstration of functional assembly of benzodiazepine-responsive sites. Proc Natl Acad Sci. 1992;89:6378–6382. doi: 10.1073/pnas.89.14.6378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 169.Horne AL, Hadingham KL, Macaulay AJ, et al. The pharmacology of recombinant GABAA receptors containing bovine α1, β1, γ2L sub-units stably transfected into mouse fibroblast L-cells. Br J Pharmacol. 1992;107:732–737. doi: 10.1111/j.1476-5381.1992.tb14515.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 170.Krishek BJ, Amato A, Connolly CN, et al. Proton sensitivity of the GABA(A) receptor is associated with the receptor subunit composition. J Physiol. 1996;492:431–443. doi: 10.1113/jphysiol.1996.sp021319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 171.Saxena NC, Macdonald RL. Properties of putative cerebellar gamma-aminobutyric acid A receptor isoforms. Mol Pharmacol. 1996;49:567–579. [PubMed] [Google Scholar]
  • 172.Kleingoor C, Wieland H, Korpi ER, et al. Current potentiation by diazepam but not GABA sensitivity is determined by a single histidine residue. NeuroReport. 1993;4:187–190. doi: 10.1097/00001756-199302000-00018. [DOI] [PubMed] [Google Scholar]
  • 173.Amin J, Weiss DS. GABAA receptor needs two homologous domains of the & beta;-subunit for activation by GABA but not by pentobarbital. Nature. 1993;366:565–569. doi: 10.1038/366565a0. [DOI] [PubMed] [Google Scholar]
  • 174.Chang Y, Wang R, Barot S, Weiss DS. Stoichiometry of a recombinant GABAA receptor. J Neurosci. 1996;16:5415–5424. doi: 10.1523/JNEUROSCI.16-17-05415.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 175.Baumann SW, Baur R, Sigel E. Individual properties of the two functional agonist sites in GABAA receptors. J Neurosci. 2003;23:11158–11166. doi: 10.1523/JNEUROSCI.23-35-11158.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 176.Connolly CN, Krishek BJ, McDonald BJ, et al. Assembly and cell surface expression of heteromeric and homomeric-aminobutyric acid type A receptors. J Biol Chem. 1996;271:89–96. doi: 10.1074/jbc.271.1.89. [DOI] [PubMed] [Google Scholar]
  • 177.Falk-Petersen C, Tsonkov T, Nielsen MS, et al. Discovery of a new class of orthosteric antagonists with nanomolar potency at extrasynaptic GABAA receptors. Sci Rep. 2020;10:10078. doi: 10.1038/s41598-020-66821-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 178.Herb A, Wisden W, Luddens H, et al. The third gamma subunit of the gamma-aminobutyric acid type A receptor family. Proc Natl Acad Sci USA. 1992;89:1433–1437. doi: 10.1073/pnas.89.4.1433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 179.L’Estrade E, Hansen H, Falk-Petersen C, et al. Synthesis and pharmacological evaluation of [11C]4-methoxy-N-[2-(thiophen-2-yl)imidazo[1,2-a]pyridin-3-yl]benzamide as a brain penetrant PET ligand selective for the d-subunit-containing gamma-aminobutyric acid type A receptors. ACS Omega. 2019;4:8846–8851. doi: 10.1021/acsomega.9b00434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 180.Mortensen M, Smart TG. Extrasynaptic αβ subunit GABA A receptors on rat hippocampal pyramidal neurons: extrasynaptic GABAA receptor isoforms. J Physiol. 2006;577:841–856. doi: 10.1113/jphysiol.2006.117952. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 181.Feng H-J, Macdonald RL. Proton modulation of α1β3δ GABAA receptor channel gating and desensitization. J Neurophysiol. 2004;92:1577–1585. doi: 10.1152/jn.00285.2004. [DOI] [PubMed] [Google Scholar]
  • 182.Nagaya N, Macdonald RL. Two γ2L subunit domains confer low Zn2+ sensitivity to ternary GABAA receptors. J Physiol. 2001;532:17–30. doi: 10.1111/j.1469-7793.2001.0017g.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 183.Wafford KA, Whiting PJ, Kemp JA. Differences in affinity and efficacy of benzodiazepine receptor ligands at recombinant gamma-aminobutyric acidA receptor subtypes. Mol Pharmacol. 1993;43:240–244. [PubMed] [Google Scholar]
  • 184.Jones MV, Harrison NL, Pritchett DB, Hales TG. Modulation of the GABAA receptor by propofol is independent of the gamma subunit. J Pharmacol Exp Ther. 1995;274:962–968. [PubMed] [Google Scholar]
  • 185.Davies PA, Hanna MC, Hales TG, Kirkness EF. Insensitivity to anaesthetic agents conferred by a class of GABAA receptor subunit. Nature. 1997;385:820–823. doi: 10.1038/385820a0. [DOI] [PubMed] [Google Scholar]
  • 186.Ranna M, Sinkkonen S, Möykkynen T, et al. Impact of ε and θ subunits on pharmacological properties of α3β1 GABAA receptors expressed in Xenopus oocytes. BMC Pharmacol. 2006;6:1. doi: 10.1186/1471-2210-6-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 187.Knoflach F, Drescher U, Scheurer L, et al. Full and partial agonism displayed by benzodiazepine receptor ligands at recombinant ‘y-aminobutyric acidA receptor subtypes. J Pharmacol Exp Ther. 1993;266:385–391. [PubMed] [Google Scholar]
  • 188.Falk-Petersen C, Sogaard R, Madsen K, et al. Develpment of a robus mammalian cell-based assay for studying recombinant a4b1/3D GABAA receptor subtypes. Basic Clin Pharmacol Toxicol. 2017;121:119–129. doi: 10.1111/bcpt.12778. [DOI] [PubMed] [Google Scholar]
  • 189.Knoflach F, Benke D, Wang Y, et al. Pharmacological modulation of the diazepam-insensitive recombinant gamma-aminobutyric acidA receptors alpha 4 beta 2 gamma 2 and alpha 6 beta 2 gamma 2. Mol Pharmacol. 1996;50:1253–1261. [PubMed] [Google Scholar]
  • 190.Knoflach F, Rhyner Th, Villa M, et al. The γ3-subunit of the GABAA-receptor confers sensitivity to benzodiazepine receptor ligands. FEBS Lett. 1991;293:191–194. doi: 10.1016/0014-5793(91)81184-A. [DOI] [PubMed] [Google Scholar]
  • 191.Neelands TR, Macdonald RL. Incorporation of the π subunit into functional γ-aminobutyric acidA receptors. Mol Pharmacol. 1999;56:598–610. doi: 10.1124/mol.56.3.598. [DOI] [PubMed] [Google Scholar]
  • 192.Qian H, Dowling JE, Ripps H. Molecular and pharmacological properties of GABA-rho subunits from white perch retina. Dev Neurobiol. 1998;37:305–320. doi: 10.1002/(SICI)1097-4695(19981105)37:2&#x0003c;305::AID-NEU9&#x0003e;3.0.CO;2-6. [DOI] [PubMed] [Google Scholar]
  • 193.Nguyen Q-A, Nicoll RA. The GABAA receptor β subunit is required for inhibitory transmission. Neuron. 2018;98:718–725. doi: 10.1016/j.neuron.2018.03.046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 194.Craig AM. Selective clustering of glutamate and gamma-aminobutyric acid receptors opposite terminals releasing the corresponding neurotransmitters. Proc Natl Acad Sci USA. 1994;91:12373–12377. doi: 10.1073/pnas.91.26.12373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 195.Celentano JJ, Wong RK. Multiphasic desensitization of the GABAA receptor in outside-out patches. Biophys J. 1994;66:1039–1050. doi: 10.1016/S0006-3495(94)80885-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 196.Nusser Z, Sieghart W, Somogyi P. Segregation of different GABAA receptors to synaptic and extrasynaptic membranes of cerebellar granule cells. J Neurosci. 1998;18:1693–1703. doi: 10.1523/JNEUROSCI.18-05-01693.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 197.Essrich C, Lorez M, Benson JA, et al. Postsynaptic clustering of major GABAA receptor subtypes requires the γ2 subunit and gephyrin. Nat Neurosci. 1998;1:563–571. doi: 10.1038/2798. [DOI] [PubMed] [Google Scholar]
  • 198.Farrant M, Nusser Z. Variations on an inhibitory theme: phasic and tonic activation of GABAA receptors. Nat Rev Neurosci. 2005;6:215–229. doi: 10.1038/nrn1625. [DOI] [PubMed] [Google Scholar]
  • 199.Adkins CE, Pillai GV, Kerby J, et al. α4β3δ GABAA receptors characterized by fluorescence resonance energy transfer-derived measurements of membrane potential. J Biol Chem. 2001;276:38934–38939. doi: 10.1074/jbc.M104318200. [DOI] [PubMed] [Google Scholar]
  • 200.Wall MJ, Usowicz MM. Development of action potential-dependent and independent spontaneous GABAA receptor-mediated currents in granule cells of postnatal rat cerebellum. Eur J Neurosci. 1997;9:533–548. doi: 10.1111/j.1460-9568.1997.tb01630.x. [DOI] [PubMed] [Google Scholar]
  • 201.Gurba KN. Assembly and heterogeneity of GABAA receptors. Vanderbilt Rev Neurosci. 2010;1–2:25–32. [Google Scholar]
  • 202.Scimemi A, Beato M. Determining the neurotransmitter concentration profile at active synapses. Mol Neurobiol. 2009;40:289–306. doi: 10.1007/s12035-009-8087-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 203.Galarreta M, Hestrin S. Frequency-dependent synaptic depression and the balance of excitation and inhibition in the neocortex. Nat Neurosci. 1998;1:587–594. doi: 10.1038/2822. [DOI] [PubMed] [Google Scholar]
  • 204.Jiang L, Sun S, Nedergaard M, Kang J. Paired-pulse modulation at individual GABAergic synapses in rat hippocampus. J Physiol. 2000;523:425–439. doi: 10.1111/j.1469-7793.2000.t01-1-00425.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 205.Levitan ES, Schofield PR, Burt DR, et al. Structural and functional basis for GABAA receptor heterogeneity. Nature. 1988;335:76–79. doi: 10.1038/335076a0. [DOI] [PubMed] [Google Scholar]
  • 206.Nusser Z, Sieghartt W, Benket D, et al. Differential synaptic localization of two major gamma-aminobutyric acid type A receptor alpha subunits on hippocampal pyramidal cells. Proc Natl Acad Sci USA. 1996;93:11939–11944. doi: 10.1073/pnas.93.21.11939. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 207.Nusser Z, Sieghart W, Stephenson FA, Somogyil P. The alpha6 subunit of the GABA, receptor is concentrated in both inhibitory and excitatory synapses on cerebellar granule cells. J Neurosci. 1996;16:103–114. doi: 10.1523/JNEUROSCI.16-01-00103.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 208.Koulen P, Tter JHB, Ger SK, et al. Immunocytochemical localization of the GABAC receptor r subunits in the cat, goldfish, and chicken retina. J Comp Neurol. 1997;380:520–532. doi: 10.1002/(SICI)1096-9861(19970421)380:4&#x0003c;520::AID-CNE8&#x0003e;3.0.CO;2-3. [DOI] [PubMed] [Google Scholar]
  • 209.Huntsman MM, Huguenard JR. Fast IPSCs in rat thalamic reticular nucleus require the GABAA receptor β1 subunit: molecular basis of fast IPSCs in RTN cells. J Physiol. 2006;572:459–475. doi: 10.1113/jphysiol.2006.106617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 210.Enz R. Immunocytochemical localization of the GABAC receptor subunits in the mammalian retina. J Neurosci. 1996;16:4479–4490. doi: 10.1523/JNEUROSCI.16-14-04479.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 211.Pan Z, Lipton S. Multiple GABA receptor subtypes mediate inhibition of calcium influx at rat retinal bipolar cell terminals. J Neurosci. 1995;15:2668–2679. doi: 10.1523/JNEUROSCI.15-04-02668.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 212.Kapousta-Bruneau NV. Opposite effects of GABAA and GABAC receptor antagonists on the b-wave of ERG recorded from the isolated rat retina. Vis Res. 2000;40:1653–1665. doi: 10.1016/S0042-6989(00)00028-6. [DOI] [PubMed] [Google Scholar]
  • 213.Shields CR, Tran MN, Wong ROL, Lukasiewicz PD. Distinct ionotropic GABA receptors mediate presynaptic and postsynaptic inhibition in retinal bipolar cells. J Neurosci. 2000;20:2673–2682. doi: 10.1523/JNEUROSCI.20-07-02673.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 214.Euler T, Wässle H. Different contributions of GABA A and GABA C receptors to rod and cone bipolar cells in a rat retinal slice preparation. J Neurophysiol. 1998;79:1384–1395. doi: 10.1152/jn.1998.79.3.1384. [DOI] [PubMed] [Google Scholar]
  • 215.Zhang J, Jung C-S, Slaughter MM. Serial inhibitory synapses in retina. Vis Neurosci. 1997;14:553–563. doi: 10.1017/S0952523800012219. [DOI] [PubMed] [Google Scholar]
  • 216.Carlson BX, Elster L, Schousboe A. Pharmacological and functional implications of developmentally-regulated changes in GABAA receptor subunit expression in the cerebellum. Eur J Pharmacol. 1998;352:1–14. doi: 10.1016/S0014-2999(98)00355-0. [DOI] [PubMed] [Google Scholar]
  • 217.Tia S, Wang JF, Kotchabhakdi N, Vicini S. Developmental changes of inhibitory synaptic currents in cerebellar granule neurons: role of GABAA receptor α6 subunit. J Neurosci. 1996;16:3630–3640. doi: 10.1523/JNEUROSCI.16-11-03630.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 218.Quick M, Corey JL, Davidson N, Lester HA. Second messengers, trafficking-related proteins, and amino acid residues that contribute to the functional regulation of the rat brain GABA transporter GAT1. J Neurosci. 1997;17:2967–2979. doi: 10.1523/JNEUROSCI.17-09-02967.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 219.Corey JL, DavidsonS N, Lester HA, Brechan N. Protein kinase C modulates the activity of a cloned y-aminobutyric acid transporter expressed in Xenopus oocytes via regulated subcellular redistribution of the transporter. J Biol Chem. 1994;269:14759–14767. doi: 10.1016/S0021-9258(17)36690-5. [DOI] [PubMed] [Google Scholar]
  • 220.Gulledge AT, Stuart GJ. Excitatory actions of GABA in the cortex. Neuron. 2003;37:299–309. doi: 10.1016/S0896-6273(02)01146-7. [DOI] [PubMed] [Google Scholar]
  • 221.Williams SR, Stuart GJ. Voltage- and site-dependent control of the somatic impact of dendritic IPSPs. J Neurosci. 2003;23:7358–7367. doi: 10.1523/JNEUROSCI.23-19-07358.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 222.Hamann M, Rossi DJ, Attwell D. Tonic and spillover inhibition of granule cells control information flow through cerebellar cortex. Neuron. 2002;33:625–633. doi: 10.1016/S0896-6273(02)00593-7. [DOI] [PubMed] [Google Scholar]
  • 223.Banks MI, Pearce RA. Kinetic differences between synaptic and extrasynaptic GABAA receptors in CA1 pyramidal cells. J Neurosci. 2000;20:937–948. doi: 10.1523/JNEUROSCI.20-03-00937.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 224.Li P, Akk G. Synaptic-type α1β2γ2L GABAA receptors produce large persistent currents in the presence of ambient GABA and anesthetic drugs. Mol Pharmacol. 2015;87:776–781. doi: 10.1124/mol.114.096453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 225.Semyanov A, Walker MC, Kullmann DM. GABA uptake regulates cortical excitability via cell type–specific tonic inhibition. Nat Neurosci. 2003;6:484–490. doi: 10.1038/nn1043. [DOI] [PubMed] [Google Scholar]
  • 226.Maex R, Schutter ED. Synchronization of golgi and granule cell firing in a detailed network model of the cerebellar granule cell layer. J Neurophysiol. 1998;80:2521–2537. doi: 10.1152/jn.1998.80.5.2521. [DOI] [PubMed] [Google Scholar]
  • 227.De Schutter E. Cerebellar cortex: computation by extrasynaptic inhibition? Curr Biol. 2002;12:R363–R365. doi: 10.1016/S0960-9822(02)00861-8. [DOI] [PubMed] [Google Scholar]
  • 228.Schweighofer N, Doya K, Lay F. Unsupervised learning of granule cell sparse codes enhances cerebellar adaptive control. Neuroscience. 2001;103:35–50. doi: 10.1016/S0306-4522(00)00548-0. [DOI] [PubMed] [Google Scholar]
  • 229.Tyrrell T, Willshaw D. Cerebellar cortex: its simulation and the relevance of Marr’s theory. Phil Trans R Soc Lond B. 1992;336:239–257. doi: 10.1098/rstb.1992.0059. [DOI] [PubMed] [Google Scholar]
  • 230.Hámori J, Somogyi J. Differentiation of cerebellar mossy fiber synapses in the rat: a quantitative electron microscope study. J Comp Neurol. 1983;220:365–377. doi: 10.1002/cne.902200402. [DOI] [PubMed] [Google Scholar]
  • 231.Demarque M, Represa A, Becq H, et al. Paracrine intercellular communication by a Ca2+- and SNARE-independent release of GABA and glutamate prior to synapse formation. Neuron. 2002;36:1051–1061. doi: 10.1016/S0896-6273(02)01053-X. [DOI] [PubMed] [Google Scholar]
  • 232.Mitchell SJ, Silver RA. Shunting inhibition modulates neuronal gain during synaptic excitation. Neuron. 2003;38:433–445. doi: 10.1016/S0896-6273(03)00200-9. [DOI] [PubMed] [Google Scholar]
  • 233.Attwell D, Barbour B, Szatkowski M. Nonvesicular release of neurotransmitter. Neuron. 1993;11:401–407. doi: 10.1016/0896-6273(93)90145-H. [DOI] [PubMed] [Google Scholar]
  • 234.Birnir B, Everitt AB, Lim MSF, Gage PW. Spontaneously opening GABAA channels in CA1 pyramidal neurones of rat hippocampus. J Membr Biol. 2000;174:21–29. doi: 10.1007/s002320001028. [DOI] [PubMed] [Google Scholar]
  • 235.Rossi DJ, Hamann M. Spillover-mediated transmission at inhibitory synapses promoted by high affinity α6 subunit GABAA receptors and glomerular geometry. Neuron. 1998;20:783–795. doi: 10.1016/S0896-6273(00)81016-8. [DOI] [PubMed] [Google Scholar]
  • 236.Barbour B, Häusser M. Intersynaptic diffusion of neurotransmitter. Trends Neurosci. 1997;20:377–384. doi: 10.1016/s0166-2236(96)20050-5. [DOI] [PubMed] [Google Scholar]
  • 237.Rudomín P, Engberg I, Jiménez I. Mechanisms involved in presynaptic depolarization of group I and rubrospinal fibers in cat spinal cord. J Neurophysiol. 1981;46:532–548. doi: 10.1152/jn.1981.46.3.532. [DOI] [PubMed] [Google Scholar]
  • 238.Curtis DR, Lodge D. The depolarization of feline ventral horn group Ia spinal afferent terminations by GABA. Exp Brain Res. 1982;46:215–233. doi: 10.1007/BF00237180. [DOI] [PubMed] [Google Scholar]
  • 239.Stell BM, Rostaing P, Triller A, Marty A. Activation of presynaptic GABAA receptors induces glutamate release from parallel fiber synapses. J Neurosci. 2007;27:9022–9031. doi: 10.1523/JNEUROSCI.1954-07.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 240.Stuart GJ, Redman SJ. The role of GABAA and GABAB receptors in presynaptic inhibition of Ia EPSPs in cat spinal motoneurones. J Physiol. 1992;447:675–692. doi: 10.1113/jphysiol.1992.sp019023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 241.Pouille F. Enforcement of Temporal fidelity in pyramidal cells by somatic feed-forward inhibition. Science. 2001;293:1159–1163. doi: 10.1126/science.1060342. [DOI] [PubMed] [Google Scholar]
  • 242.Walker MC, Ruiz A, Kullmann DM. Monosynaptic GABAergic signaling from dentate to CA3 with a pharmacological and physiological profile typical of mossy fiber synapses. Neuron. 2001;29:703–715. doi: 10.1016/S0896-6273(01)00245-8. [DOI] [PubMed] [Google Scholar]
  • 243.Bergersen L, Ruiz A, Bjaalie JG, et al. GABA and GABAA receptors at hippocampal mossy fibre synapses. Eur J Neurosci. 2003;18:931–941. doi: 10.1046/j.1460-9568.2003.02828.x. [DOI] [PubMed] [Google Scholar]
  • 244.Pouzat C, Marty A. Somatic recording of GABAergic autoreceptor current in cerebellar stellate and basket cells. J Neurosci. 1999;19:1675–1690. doi: 10.1523/JNEUROSCI.19-05-01675.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 245.Rudomin P, Schmidt RF. Presynaptic inhibition in the vertebrate spinal cord revisited. Exp Brain Res. 1999;129:1–37. doi: 10.1007/s002210050933. [DOI] [PubMed] [Google Scholar]
  • 246.Sagdullaev BT, McCall MA, Lukasiewicz PD. Presynaptic inhibition modulates spillover, creating distinct dynamic response ranges of sensory output. Neuron. 2006;50:923–935. doi: 10.1016/j.neuron.2006.05.015. [DOI] [PubMed] [Google Scholar]
  • 247.Filippova N, Dudley R, Weiss DS. Evidence for phosphorylation-dependent internalization of recombinant human ρ1 GABAC receptors. J Physiol. 1999;518:385–399. doi: 10.1111/j.1469-7793.1999.0385p.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 248.Leidenheimer NJ, Whiting PJ, Harris RA. Activation of calcium-phospholipid-dependent protein kinase enhances benzodiazepine and barbiturate potentiation of the GABAA receptor. J Neurochem. 1993;60:1972–1975. doi: 10.1111/j.1471-4159.1993.tb13432.x. [DOI] [PubMed] [Google Scholar]
  • 249.Gyenes M, Wang Q, Gibbs T, Farb H. Phosphorylation factors control neurotransmitter and actions at the gamma-aminobutyric acid type A receptor. Mol Pharmacol. 1994;46:542–549. [PubMed] [Google Scholar]
  • 250.Moss S, Smart T, Blackstone C, Huganir R. Functional modulation of GABAA receptors by cAMP-dependent protein phosphorylation. Science. 1992;257:661–665. doi: 10.1126/science.1323140. [DOI] [PubMed] [Google Scholar]
  • 251.Poisbeau P, Cheney MC, Browning MD, Mody I. Modulation of synaptic GABAA receptor function by PKA and PKC in adult hippocampal neurons. J Neurosci. 1999;19:674–683. doi: 10.1523/JNEUROSCI.19-02-00674.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 252.Kapur J, Macdonald RL. Cyclic AMP-dependent protein kinase enhances hippocampal dentate granule cell GABAA receptor currents. J Neurophysiol. 1996;76:2626–2634. doi: 10.1152/jn.1996.76.4.2626. [DOI] [PubMed] [Google Scholar]
  • 253.Cheun JE, Yeh HH. Modulation of GABAA receptor-activated current by norepinephrine in cerebellar purkinje cells. Neuroscience. 1992;51:951–960. doi: 10.1016/0306-4522(92)90532-7. [DOI] [PubMed] [Google Scholar]
  • 254.Collinson N, Cothliff R, Rosahl TW, et al. European journal of neuroscience. Oxford: Blackwell Science Ltd; 2000. Role of the alpha 5 subunit of the GABA-A receptor in learning and memory; pp. 171–171. [Google Scholar]
  • 255.Hinkle DJ, Macdonald RL. Beta subunit phosphorylation selectively increases fast desensitization and prolongs deactivation of alpha1beta1gamma2L and alpha1beta3gamma2L GABAA receptor currents. J Neurosci. 2003;23:11698–11710. doi: 10.1523/JNEUROSCI.23-37-11698.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 256.Liu F, Wan Q, Pristupa ZB, et al. Direct protein–protein coupling enables cross-talk between dopamine D5 and γ-aminobutyric acid A receptors. Nature. 2000;403:274–280. doi: 10.1038/35002014. [DOI] [PubMed] [Google Scholar]
  • 257.Sokolova E, Nistri A, Giniatullin R. Negative cross talk between anionic GABAA and cationic P2X ionotropic receptors of rat dorsal root ganglion neurons. J Neurosci. 2001;21:4958–4968. doi: 10.1523/JNEUROSCI.21-14-04958.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 258.Lewis CA, Faber DS. GABA responses and their partial occlusion by glycine in cultured rat medullary neurons. Neuroscience. 1993;52:83–96. doi: 10.1016/0306-4522(93)90184-H. [DOI] [PubMed] [Google Scholar]
  • 259.Li Y, Wu L-J, Legendre P, Xu T-L. Asymmetric cross-inhibition between GABAA and glycine receptors in rat spinal dorsal horn neurons. J Biol Chem. 2003;278:38637–38645. doi: 10.1074/jbc.M303735200. [DOI] [PubMed] [Google Scholar]
  • 260.Muir J, Arancibia-Carcamo IL, MacAskill AF, et al. NMDA receptors regulate GABAA receptor lateral mobility and clustering at inhibitory synapses through serine 327 on the 2 subunit. Proc Natl Acad Sci. 2010;107:16679–16684. doi: 10.1073/pnas.1000589107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 261.Petrini EM, Zacchi P, Barberis A, et al. Declusterization of GABAA receptors affects the kinetic properties of GABAergic currents in cultured hippocampal neurons. J Biol Chem. 2003;278:16271–16279. doi: 10.1074/jbc.M213081200. [DOI] [PubMed] [Google Scholar]
  • 262.Petrini EM, Marchionni I, Zacchi P, et al. Clustering of extrasynaptic GABAA receptors modulates tonic inhibition in cultured hippocampal neurons. J Biol Chem. 2004;279:45833–45843. doi: 10.1074/jbc.M407229200. [DOI] [PubMed] [Google Scholar]
  • 263.Chen L, Wang H, Vicini S, Olsen RW. The gamma-aminobutyric acid type A (GABAA) receptor-associated protein (GABARAP) promotes GABAA receptor clustering and modulates the channel kinetics. Proc Natl Acad Sci. 2000;97:11557–11562. doi: 10.1073/pnas.190133497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 264.Weiss DS. Membrane potential modulates the activation of GABA-gated channels. J Neurophysiol. 1988;59:514–527. doi: 10.1152/jn.1988.59.2.514. [DOI] [PubMed] [Google Scholar]
  • 265.Akaike N, Oyama Y, Yakushiji T. Influences of external Ca2+ on the GABA-induced chloride current and the efficacy of diazepam in internally perfused frog sensory neurons. Brain Res. 1989;504:293–296. doi: 10.1016/0006-8993(89)91371-1. [DOI] [PubMed] [Google Scholar]
  • 266.Kaneda M, Mochizuki M, Aoki K, Kaneko A. Modulation of GABAC response by Ca2+ and other divalent cations in horizontal cells of the catfish retina. J Genet Physiol. 1997;110:741–747. doi: 10.1085/jgp.110.6.741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 267.Akopian A, Gabriel R, Witkovsky P. Calcium released from intracellular stores inhibits GABAA-mediated currents in ganglion cells of the turtle retina. J Neurophysiol. 1998;80:1105–1115. doi: 10.1152/jn.1998.80.3.1105. [DOI] [PubMed] [Google Scholar]
  • 268.De Koninck Y, Mody I. The effects of raising intracellular calcium on synaptic GABAA receptor-channels. Neuropharmacology. 1996;35:1365–1374. doi: 10.1016/S0028-3908(96)00063-9. [DOI] [PubMed] [Google Scholar]
  • 269.Taleb O, Trouslard J, Demeneix BA, et al. Spontaneous and GABA-evoked chloride channels on pituitary intermediate lobe cells and their internal Ca requirements. Pflugers Arch Eur J Physiol. 1987;409:620–631. doi: 10.1007/BF00584663. [DOI] [PubMed] [Google Scholar]
  • 270.Frederickson CJ, Danscher G. Progress in brain research. Elsevier; 1990. Chapter 6 zinc-containing neurons in hippocampus and related CNS structures; pp. 71–84. [DOI] [PubMed] [Google Scholar]
  • 271.Smart TG. A novel modulatory binding site for zinc on the GABAA receptor complex in cultured rat neurones. J Physiol. 1992;447:587–625. doi: 10.1113/jphysiol.1992.sp019020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 272.Smart TG, Moss SJ, Xie X, Huganir RL. GABAA receptors are differentially sensitive to zinc: dependence on subunit composition. Br J Pharmacol. 1991;103:1837–1839. doi: 10.1111/j.1476-5381.1991.tb12337.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 273.Krishek BJ, Moss SJ, Smart TG. Interaction of H+ and Zn2+ on recombinant and native rat neuronal GABAA receptors. J Physiol. 1998;507:639–652. doi: 10.1111/j.1469-7793.1998.639bs.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 274.Hosie AM, Dunne EL, Harvey RJ, Smart TG. Zinc-mediated inhibition of GABAA receptors: discrete binding sites underlie subtype specificity. Nat Neurosci. 2003;6:362–369. doi: 10.1038/nn1030. [DOI] [PubMed] [Google Scholar]
  • 275.Pasternack M, Bountra C, Voipio J, Kaila K. Influence of extracellular and intracellular pH on GABA-gated chloride conductance in crayfish muscle fibres. Neuroscience. 1992;47:921–929. doi: 10.1016/0306-4522(92)90040-9. [DOI] [PubMed] [Google Scholar]
  • 276.Kisiel M, Jatczak-Śliwa M, Mozrzymas JW. Protons modulate gating of recombinant α1β2γ2 GABAA receptor by affecting desensitization and opening transitions. Neuropharmacology. 2019;146:300–315. doi: 10.1016/j.neuropharm.2018.10.016. [DOI] [PubMed] [Google Scholar]
  • 277.Rivera C, Wegelius K, Reeben M, et al. Different sensitivities of human and rat ρ1 GABA receptors to extracellular pH. Neuropharmacology. 2000;39:977–989. doi: 10.1016/S0028-3908(99)00208-7. [DOI] [PubMed] [Google Scholar]
  • 278.Wegelius K, Reeben M, Rivera C, et al. The rho 1 GABA receptor cloned from rat retina is down-modulated by protons. NeuroReport. 1996;7:2005–2009. doi: 10.1097/00001756-199608120-00030. [DOI] [PubMed] [Google Scholar]
  • 279.Onodera K, Takeuchi A. An analysis of the inhibitory post-synaptic current in the voltage-clamped crayfish muscle. J Physiol. 1979;286:265–282. doi: 10.1113/jphysiol.1979.sp012618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 280.Limon A, Delbruck E, Yassine A, et al. Electrophysiological evaluation of extracellular spermine and alkaline pH on synaptic human GABAA receptors. Transl Psychiatry. 2019;9:218. doi: 10.1038/s41398-019-0551-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 281.Krishtal OA, Osipchuk YuV, Shelest TN, Smirnoff SV. Rapid extracellular pH transients related to synaptic transmission in rat hippocampal slices. Brain Res. 1987;436:352–356. doi: 10.1016/0006-8993(87)91678-7. [DOI] [PubMed] [Google Scholar]
  • 282.Traynelis S, Hartley M, Heinemann S. Control of proton sensitivity of the NMDA receptor by RNA splicing and polyamines. Science. 1995;268:873–876. doi: 10.1126/science.7754371. [DOI] [PubMed] [Google Scholar]
  • 283.Sinning A, Hübner CA. Minireview: pH and synaptic transmission. FEBS Lett. 2013;587:1923–1928. doi: 10.1016/j.febslet.2013.04.045. [DOI] [PubMed] [Google Scholar]
  • 284.Kaila K, Saarikoski J, Voipio J. Mechanism of action of GABA on intracellular pH and on surface pH in crayfish muscle fibres. J Physiol. 1990;427:241–260. doi: 10.1113/jphysiol.1990.sp018170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 285.El-Beheiry H, Puil E. Effects of hypomagnesia on transmitter actions in neocortical slices. Br J Pharmacol. 1990;101:1006–1010. doi: 10.1111/j.1476-5381.1990.tb14197.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 286.Duchen MR, Valdeolmillos M, O’Neill SC, Eisner DA. Effects of metabolic blockade on the regulation of intracellular calcium in dissociated mouse sensory neurones. J Physiol. 1990;424:411–426. doi: 10.1113/jphysiol.1990.sp018074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 287.Inoue M, Oomura Y, Yakushiji T, Akaike N. Intracellular calcium ions decrease the affinity of the GABA receptor. Nature. 1986;324:156–158. doi: 10.1038/324156a0. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

All data relevant to this review is included in the text, references and figs.

Not applicable.


Articles from Cellular and Molecular Life Sciences: CMLS are provided here courtesy of Springer

RESOURCES